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SUMMARY
This study examined the effects of drugs in vascular smooth muscle. 
Mechanical responses to vasoconstrictors and vasorelaxants were examined and 
correlated with the corresponding biochemical mechanisms that regulate vascular 
tone. Responses to drugs were examined in isolated segments of rat aorta and tail 
artery.
The main areas of research were:
1. A study of the mechanical responses to vasoconstrictors and vasorelaxants in 
isolated vasculature from Wistar rats and of how these responses are altered in 
vasculature from spontaneously hypertensive rats (SHR) and from the appropriate 
normotensive Wistar Kyoto (WKY) controls.
2. A study of the effect of vasoconstrictors and vasorelaxants on the second 
messengers (inositol phosphates, and cyclic nucleotides) involved in contraction and 
relaxation in vascular smooth muscle and of how these biochemical responses are 
altered in vasculature from SHR.
3. A study of the interactions between the second messengers involved in 
modulating tone in vasculature from Wistar rats and from SHR and WKY rats.
The principal methods used were:
1. Measurement of contractions and relaxations of isolated aortic rings and of 
pressor responses to vasoconstrictors in perfused isolated tail artery segments.
2. Radiochemical measurement of agonist-induced accumulation of (^-inosito l 
phosphates (IPs) in isolated aortic rings, pre-incubated in fHJ-myo-inositol.
3. Radiochemical measurement by radio-immunoassay of drug-induced changes in 
the levels of cyclic adenosine monophospate (cAMP) and cyclic guanosine 
monophosphate (cGMP) in isolated arterial rings.
4. Measurement of blood pressure in the conscious rat by the tail cuff method. 
The principal results obtained in this study are summarized below:
1. The vasoconstrictor, noradrenaline (NA, 1040 -10’5M) produced concentration- 
dependent contractions of rat isolated aortic rings. KC1 (10‘2 -104M) also caused 
concentration- dependent contractions.
2. The endothelium-dependent vasorelaxnt, acetylcholine (ACh, 3x1 O'9 -3xlO‘6M)
and the endothelium-independent vasorelaxant, sodium nitroprusside (SNP, 10'10
-3x1 O^M) relaxed isolated aortic rings that had been precontracted with NA (EC^, 
3xlO"8M).
3. Isoprenaline (ISO, 3x1 O'9 -10'7M) relaxed isolated aortic rings that had been 
precontracted with NA (EC,S, 3xlO*8M).
4. NA (10-8 -10'3M) increased the accumulation of ^fty-inositol phosphates in 
aortic rings from Wistar rats in a concentration dependent manner.
5. The ability of NA (10"5M) to increase the accumulation of (3H)-inositol 
phosphates was inhibited by the alphaj -adrenoceptor antagonist, prazosin (PRAZ, 
10~6M). These results suggest that the ability of NA to increase the 
accumulation of inositol phosphates (IPs) in rat aortic rings is an alphaj- 
adrenoceptor-mediated response.
6. KC1 QxlO^M) also increased the accumulation of IPs in isolated aortic rings from 
Wistar rats. This result suggests that the KCl-induced influx of Ca2+ may cause 
a Pl-response, perhaps as a result of activation of phospholipase-C.
7. ACh (10‘5M) and SNP (lO^M) caused concentration-dependent accumulation
•*s
of cyclic guanosine monophosphate (cGMP) in aortic rings in the presence of NA 
(EC75, 3x10'8M).
8. The beta-adrenoceptor agonist, ISO (10r8M) and the directly-acting
xiv
relaxant, forskolin (FOR, 10^M) increased the accumulation of cAMP in isolated 
aortic rings from Wistar rats.
9. The cGMP-increasing drugs ACh (10'5M) and SNP (lO^M) and also the 
permeant cGMP analogue, 8-bromo-cGMP (0.3mM) inhibited the NA-induced 
Pl-response in isolated aortic rings from Wistar rats.
10. ACh did not inhibit the Pl-response in isolated aortic rings in which the 
endothelium had been removed mechanically by rubbing or chemically by Triton 
X-100(0.1% V/V).
11. ISO (10‘6M), salbutamol (SAL, 10*6M) and the permeant cAMP analogue, 
8-Bromo-cAMP (0.3mM) also inhibited the NA-induced Pl-response.
12. The combination of SNP (10'6M), and FOR (10‘6M), additively inhibited the 
NA-induced Pl-response in isolated aortic rings.
13. Isobutylmethylxanthine (IBMX, lxlO^M) inhibited the NA-induced Pl-response 
in rat isolated aortic rings.
14. Propranolol (PROP, 5xlO*M) antagonised the inhibitory effect of ISO (lO^M) 
and SAL (10'6M) on the NA-induced Pl-response in rat isolated aortic rings.
15. The maximal inhibition of NA-induced tone produced by ACh (lxlO-6 M) was
xv
80% and produced by SNP (3xl0'8M) was 100%.
16. ACh (lO^M), SNP (10-*M), ISO (10'8M) and FOR (lO^M) all inhibited the 
Pl-response by less than 50% . These results indicate that at the concentrations in 
which these drugs can maximally inhibit the NA- induced tone, they can only 
partially inhibit NA-induced Pl-response. These results suggest that cAMP and 
cGMP may have effects other than to inhibit the Pl-response.
17. Nifedipine (NIF, 10'6M) inhibited the Pl-response in aortic rings from Wistar 
rats. This result suggests that extracellular Ca2+ may be required for the 
maintenance of the Pl-response.
18. The average systolic blood pressure (190 ±  2 mm Hg) of SHR was 
significantly higher than that (109.5 ±  2.8 mm Hg) of WKY normotensive 
controls.
19. Contractile responses of aortic rings from SHR to NA and KC1 were smaller 
than those obtained in rings from WKY.
20. Inhibitory responses of aortic rings from WKY and SHR to ACh were
similar.In contrast, inhibitory responses to low concentrations of SNP (3xlO'10-10‘9M)
were smaller in SHR than those obtained in WKY rings, but inhibitory
responses to high concentrations of SNP (3x10~8 -3xlO'7M) were larger in SHR
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than in rings from WKY controls.
21. ISO (3xl0'10-10'7M) caused concentration-dependent relaxation of NA- 
precontracted aortic rings from SHR and WKY rats. Responses to low concentrations 
of ISO (3xl010 -lxlO*8M) were smaller in rings from SHR than in rings from WKY 
controls, but responses to high concentrations of ISO (3x1 Cl8 -lxlO*7M) were not 
significantly different.
22. Low concentrations of NIF (10'9 -3xlO'8M) caused smaller inhibitions of 
NA-induced tone in aortic rings from SHR than in rings from WKY but higher 
concentrations (10~6 -3xl0‘6 M) of NIF produced larger inhibitions in rings from SHR 
than in rings from WKY.
23. Low concentrations of NA (10‘8 -10"6M) produced a larger Pl-response in isolated 
aortic rings from SHR than in rings from WKY, but with higher concentrations 
of NA (lO-5 -10‘3M) there were no significant differences. These results conflict with 
the mechanical results.
24. ACh (10'5M) and SNP (10~6M) increased the levels of cGMP in isolated aortic 
rings from SHR to a greater extent than in rings from WKY and also produced 
larger inhibitions of the NA-induced PI- response in rings from SHR than in rings 
from WKY rats.
25. ISO (10'8M) produced a smaller inhibition of the Pl-response in rings from SHR
than in those of WKY, and this was reflected in smaller ISO- induced increases 
in cAMP in rings from SHR.
26. FOR (lO^M) also produced smaller increases in cAMP in isolated aortic rings 
from SHR than in rings from WKY.
27. NA (3x1 O'9 -10*5M) produced concentration-dependent contractions in isolated 
tail artery rings from WKY and SHR rats. Lower concentrations of NA 
(3x10‘9 -10"6M) produced responses that were not significantly different in rings 
from SHR and WKY, but at higher concentrations (SxlOMO^M) tail artery rings 
from SHR were significantly more responsive to NA than those from WKY 
control rats. When these results were expressed as percentages of the maximum 
response, there were no significant differences in the responses of rings from SHR 
and WKY rats.
28. KC1 (10‘2 -lO^M) produced concentration-dependent contractions in isolated tail 
artery rings from WKY and SHR rats. Responses to KC1 were not significantly 
different in rings from SHR and WKY controls. When the results were expressed 
as percentages of the maximum response, there were no significant differences 
in the responses of rings from SHR and WKY rats.
29. NA (3xl0'9 -10'5M) produced concentration-dependent contractions in isolated 
perfused tail artery segments from SHR and WKY rats. Lower concentrations of 
NA (3x1 O'9 -3x1 O^M) produced responses that were not significantly different in
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segments from SHR and WKY rats, but at the highest concentration examined 
(10'5M) tail artery segments from SHR were significantly more responsive to NA 
than those from WKY control rats. When the results were expressed as percentages 
of the maximum response, most of the responses obtained, except those produced 
by the highest and lowest concentrations, were significantly smaller in 
segments from SHR than in those from WKY rats.
30. KC1 (10'2 -5X10*1 M) produced concentration-dependent contractions in 
isolated perfused tail artery segments from WKY and SHR rats. There were no 
significant differences between the responses to KC1 in rings from SHR and WKY 
control rats. When the results were expressed as percentages of the maximum 
response, there was no significant difference between the responses obtained in rings 
from SHR and WKY rats.
31. NA (10'6 M, 10'5M) produced concentration-dependent Pl-hydrolysis in tail artery 
segments from SHR and WKY control rats. The basal (control) level of 
Pl-hydrolysis in segments from the SHR was significantly higher than in segments 
from the WKY rats.The PI response to NA (lO^M) was not significantly different 
in segments from SHR and WKY, but a higher concentration of NA (lO^M) induced 
significantly greater Pl-hydrolysis in segments from SHR than in those from WKY 
controls.
32. The results obtained in this study indicate that the changes that occur in SHR 
are complex and cannot be attributed to a single alteration in a particular biochemical
xix
coupling mechanism. Instead, it seems likely that complex, sequential changes occur 
in SHR and our ability to identify these depends upon several factors, which 
include the age of the animal examined, the biochemical parameter determined, the 
way mechanical responses of the isolated segments of artery are measured and even 
the way the results are calculated.
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CHAPTER ONE
INTRODUCTION
SECTION 1 :H YPERTENSION
I. EPIDEMIOLOGY OF HYPERTENSION:
Hypertension is a worldwide health problem. It is a major determinant of 
coronary heart disease, which in industrialized countries is the commonest cause 
of death. It is also the chief cause of cerebrovascular disease. It has become 
the commonest reason for initiating lifetime medication, with a correspondingly 
large consumption of medical resources (Benowitz & Bourne, 1989; Ganten & 
Mulrow, 1990).
Hypertension occurs in 10% to 20% of the population. This figure varies 
depending on the level of blood pressure at which a person is classified as 
hypertensive and on the technical procedures of blood pressure measurement. 
Hypertension occurs more frequently in European countries, Japan and North 
America than in less industrialized countries and rural societies. By some 
estimates, the arterial blood pressure of 15% of the American population is 
elevated to a degree that requires medical treatment (Benowitz & Bourne, 1989; 
Ganten & Murlow, 1990; Geber & Nies, 1990). Untreated, malignant hypertension 
causes the death of 90% of patients within a year (Ganten & Murlow, 1990; Geber 
& Nies, 1990). The problem may not be revealed until end organ damage is severe 
and perhaps irreversible, usually after the occurrence of a serious 
complication. Sustained arterial hypertension damages blood vessels in the kidney, 
heart, and brain and leads to an increased incidence of renal failure, coronary
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disease and stroke. Epidemiological studies indicate that the risk of damage to 
kidney, heart and brain are directly related to the extent of blood pressure 
elevation. Even mild hypertension in young or middle-age adults increases the risk 
of eventual end organ damage at any level of blood pressure or age. The risk is 
greater in black people and relatively less in premenopausal women than in men. 
Other positive risk factors include a family history of cardiovascular disease, 
smoking, hyperlipicjjemia, diabetes, psychological stress, environmental and 
dietary factors (increased salt and perhaps decreased calcium intake) may contribute 
to the development of hypertension (Benowitz & Bourne, 1989; Ganten & 
Mulrow, 1990).
II. DEFINITION & CLASSIFICATION OF HYPERTENSION:
Hypertension can be classified in different ways, such as by etiology (primary 
or essential and secondary) or according to severity such as mild, moderate, 
labile, stable or malignant hypertension.
The World Health Organization has defined blood pressure categories:
A: Normotension: systolic less than 140 mm Hg and diastolic less than 90 mm 
Hg.
B: Borderline hypertension: systolic from 140 to 160 mm Hg and diastolic 
between 90 and 95 mm Hg.
C: Hypertension: systolic greater than 160 mm Hg and/or diastolic greater than 
95 mm Hg.
These are consensus numbers and do not take into account all the other factors
2
which influence morbidity due to an elevated blood pressure (Rose, 1986; Ganten 
& Mulrow, 1990).
HI. ETIOLOGY OF HYPERTENSION:
A specific cause of hypertension can be established in perhaps no more than 10% 
of patients. It is important to consider specific causes, however, because some 
of them such as renal artery constriction, coarctation of aorta and
phaeochromocytoma, are amenable to surgical treatment. Patients in whom no 
specific cause of hypertension can be found are said to have essential
hypertension. In most cases, elevated blood pressure is associated with an overall 
increase in resistance to flow of blood through arterioles, while cardiac output is 
usually normal. Elevated blood pressure is usually caused by a combination of 
several abnormalities (i.e.multifactorial) (Rose, 1986; Benowitz & Bourne, 1989 ).
SECTION 2: REGULATION OF BLOOD PRESSURE:
Arterial blood pressure (BP) is directly proportional to the product of the 
blood flow (cardiac output, CO) and the resistance to the passage of blood through 
precapillary arterioles (peripheral vascular resistance, PVR):
BP = CO x PVR
In both normal and hypertensive individuals, blood pressure is maintained by
moment-to-moment regulation of CO and PVR, controlled at three sites; arterioles,
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postcapillary venules (capacitance vessels) and the heart. A fourth site, the 
kidney, contributes to the maintenance of blood pressure by regulating the volume 
of the intravascular fluid. The baroreflex, mediated by sympathetic and 
parasympthetic nerves, acts in combination with humoral mechanisms, including the 
renin-angiotensin- aldosterone system, to co-ordinate these four control sites and to 
maintain normal blood pressure.
Blood pressure in a hypertensive patient is controlled by the same mechanisms that 
operate in normotensive subjects, but the baroreceptors and the renal blood 
volume pressure control system appear to be set at a higher level of blood 
pressure. (Benowitz & Bourne, 1989).
Regulation of vascular resistance to the flow of blood serves two quite different 
purposes. On the one hand, this resistance must be regulated to establish an arterial 
pressure that is sufficient to deliver an adequate blood flow to all the tissues of the 
body, although it must not so high that it damages the arteries. This function, 
is centrally regulated. The second purpose of the regulation of vascular 
resistance is that of adjusting blood flow to individual organs to meet the demand 
of their varying metabolic requirements.
The resistance to blood flow and hence the energy or pressure required to force 
blood through the vessels is dependent on the blood viscosity and on the nature 
of the vessels through which it is forced. The vascular characteristics that oppose 
the flow of blood are called "vascular hindrance" (Bohr & Webb, 1986).
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I. VASCULAR HINDRANCE:
The physiological regulation of resistance is affected by changes in the physical 
properties of the vessel through which it flows. There are several important 
physiological parameters which can alter vascular resistance, yet for practical 
purposes this regulation is mainly carried out by changes in the cross-sectional 
area of the vascular lumen. These changes are caused either by structural or 
functional alterations in the vessel wall. Functional changes are those caused 
by contraction or relaxation of the vascular smooth muscle.
A: LUMEN RADIUS:
The lumen, as it reflects the cross-sectional area of the vessel through which 
blood flows, is the major determinant of resistance to flow. This parameter is 
adjusted in the physiological regulation of resistance and is also altered in 
pathological changes in vascular resistance. The quantitative relationship 
between the radius of the lumen of the vessel and the resistance to flow was 
defined by Hagen in 1839 and is referred to as the "Hagen-poiseuille law". It is 
expressed as:
R -V *
n r 4
Where R=resistance, L=length, q=blood viscosity, r=radius, with this 
dependence of resistance on the fourth power of the radius, a 10% decrease in the 
radius causes approximately a 50% increase in resistance to flow (Bowman &
5
Rand, 1980; Guyton, 1986; Bohr & Webb, 1986).
B: OTHER STRUCTURAL DETERMINANTS:
As defined by the Hagen-Poiseuille Law, the resistance to flow also increases 
as a direct function of the length of vessel. However, there is no physiological 
process that regulates vascular resistance by changing vessel length (Bohr & Webb, 
1986).
Wall thickness also plays an important role in determining the magnitude of the 
change in resistance produced by vascular smooth muscle contraction or 
relaxation. When vascular smooth muscle contracts, the circumference of the 
vessel is reduced. If the vessel wall is thick, the tissue of the wall inside the 
contracting muscle will be forced into the lumen, reducing its cross-sectional area 
and thereby amplifying the effect of the smooth muscle contraction. Folkow 
(1978) has defined the quantitative significance of this determinant of vascular 
resistance.
The other key site for regulation of PVR and in turn blood pressure is the vascular 
smooth muscle (VSM).
II. VASCULAR SMOOTH MUSCLE:
The basic structure of an artery is shown in (Fig. 1.1). All blood vessels have 
this fundamental arrangement, a particular blood vessel being characterised by the 
proportion of each constituent. Vascular smooth muscle has been
6
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Fig. 1.1.
General structure diagram of a typical blood vessel wall. This diagram represents the layers 
of a blood vessel wall including intima, media and adven titia
comprehensively reviewed; Furchgott, 1955; Bohr, 1964; Somlyo & Somlyo, 
1968; and Gabella, 1981. The total peripheral resistance to the flow of blood 
is dependent on the level of vascular tone exerted by the resistance vessels. 
Vascular smooth muscle is specialised to maintain tone, and in contrast with 
skeletal muscle, it is well suited for maintaining tension for long periods of 
time with only minimum energy expenditure (Johansson, 1986; Bohr & Webb,
1986). Vascular tone may be defined as the degree of muscle contraction 
maintained by the blood vessel (Morgan, 1987) and is influenced by many factors 
(Vanhoutte, 1978a). Depending on the nature of these stimuli, vascular tone may 
either be extrinsic or intrinsic in nature. Extrinsic tone is caused by external 
factors such as neurotransmitter, vasoactive substances and drugs. Intrinsic 
tone however, is produced by factors such as the structure of the vessel wall. 
(Morgan, 1987).
The ultimate determinant of vascular smooth muscle tone is the rate or 
magnitude of calcium ion (Ca2+) transport across the membrane (Bohr, 1963), 
since contraction of vascular smooth muscle is secondary to a rise in the cytosolic 
free Ca2+ concentration [Ca2+]j (Bolton, 1979; Jones, 1981; Karaki, 1989). The 
effects of all vasoconstrictor and vasodilator stimuli may ultimately be mediated 
through alterations in the [Ca2+]j available to the contractile proteins (Bohr, 1963; 
Karaki, 1989).
Indeed, in cardiovascular disorders such as hypertension and myocardial 
ischaemia, increased vascular tone is associated with an elevated [Ca2+]j (Cohen, 
1983). The factors that affect tone may either be physical or chemical in nature. 
The physical factors include the structure and arrangement of the blood vessel wall,
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the length-tension relationship of smooth muscle, the temperature and osmolarity 
of the bathing medium. Chemical factors are more numerous and can be neuronal 
or humoral in origin. The vascular endothelium also plays an important role in the 
modulation of vascular smooth muscle reactivity (Furchgott, 1984).
A: PHYSICAL FACTORS:
The principal physical influences on vascular tone are the structural 
arrangement of the vascular wall and the length- tension relationship of the vascular 
smooth muscle.
I) Structure and anatomical arrangement of blood vessel wall:
The structure and tissue composition of a blood vessel wall are related to its 
function, for example, the aorta and large arteries are thick-walled vessels 
containing a high proportion of elastic elements which allow these vessels to 
act as pressure reservoirs for maintaining blood flow distribution. In contrast, 
thin-walled arterioles which regulate the flow of blood from the arterial system 
into the capillaries, are principally composed of circularly-disposed and
strongly- developed smooth muscle fibres. The degree of vascular tone exerted 
by a blood vessel is dependent on the relative proportion of smooth muscle cells 
to connective tissue, with respect to the thickness of the vessel wall. This 
arrangement also influences the access of neurotransmitters and vasoactive 
agents to receptor sites and to the mechanisms of deactivation (Vanhoutte, 1978).
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B: CHEMICAL FACTORS:
1: INNERVATION OF BLOOD VESSELS: 
a: SYMPATHETIC NERVES:
The major regulator of vascular resistance is the autonomic nervous system. 
It has been shown that in the conscious rat, sympathetic blockade resulted in 
a 33 mmHg fall in arterial pressure (Hiwatari et al., 1985). Blood vessels are 
innervated predominantly by sympathetic nerves. Exceptionally, some blood 
vessels such as the precapillary arterioles in skeletal muscle in many species, 
including man, receive a cholinergic sympathetic innervation (Rand et al., 1976; 
Guyton, 1986); these fibres release acetylcholine, therefore sympathetic nerves carry 
both vasoconstrictor and vasodilator fibres, but the most important of these are 
sympathetic vasoconstrictor fibres, which are distributed to all areas of the 
circulation. This distribution is however, greater in some tissues than in others. It 
is less important in skeletal and cardiac muscle and in the brain, whereas it has a 
powerful influence in the kidneys, gut, spleen and the skin (Guyton, 1986).
There are variations in the density of nerve distribution and in the degree of 
penetration of nerve endings into the smooth muscle layers. In most arteries the 
nerves are restricted to the adventitial- medial border, in veins they usually penetrate 
into the media (Vanhoutte & Luscher, 1986). Both in animals and man, the 
density of adrenergic innervation of blood vessels decreases progressively with 
age (Frewin et al., 1971; Waterson et al., 1974; Gerke et al., 1975). However, in 
some diseases, vascular tone is mainly regulated by sympathetic nerves (Bevan
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& Su, 1973).
Functional changes in vascular smooth muscle associated with hypertension, 
may be initiated by changes that occur in this neurogenic control of vascular 
reactivity (Vanhoutte et al., 1981; Winquist et al., 1982). Noradrenaline (NA) 
is the principal neurotransmitter by which the effects of the sympathetic nervous 
system are mediated to alter vascular smooth muscle tone. Vascular smooth 
muscle has various adrenoceptor subtypes on which NA will act. The distribution 
of these receptors varies greatly. For example, small coronary arteries have more 
beta (B) than alpha (a)-adrenoceptors, hence these small vessels respond to NA 
administration or sympathetic nerve stimulation with a dilation. In contrast, the 
smooth muscle of large coronary arteries has more a  than B-adrenoceptors, hence 
they are constricted by NA (Mulvany & Halpem, 1976). On the basis of the 
activities of specific agonists and antagonists, a-adrenoceptors have been classified 
into cq and a 2 subtypes. Pre-junctional a-adrenoceptors regulate transmitter 
release from adrenergic nerve endings, whereas post-junctional a- adrenoceptors 
mediate contraction of vascular smooth muscle (Somlyo & Somlyo, 1970; Stjame 
& Gripe, 1973; Starke et al., 1975; McGrath et al., 1989). Pre-junctional 
a-adrenoceptors were originally classified as a 2-adrenoceptors and the post­
junctional a-adrenoceptors may be either a r  or a 2-adrenoceptors or both (Langer, 
1974; Starke et al., 1975; Wikberg, 1979; Fitzgerald, 1988).
b: NON-ADRENERGIC NON-CHOLINERGIC (NANC) NERVES:
At the end of the 1960s the existence of NANC nerves was recognised by 
Bumstock and his colleagues (Bumstock, 1969). They demonstrated the existence 
of NANC nerves in the gastro-intestinal tract of all vertebrates including man, and 
in the urogenital, respiratory and cardiovascular systems. Unlike, the adrenergic 
and cholinergic divisions of the autonomic nervous system, which were named 
according to the neurotransmitters released from the nerves, the NANC nerves 
could not be named in this way because of the multiplicity of possible 
transmitters that mediate the responses of NANC nerves, and therefore these nerves 
were named non-adrenergic non-cholinergic.
In 1970, Bumstock and his co-workers concluded that among many substances, 
ATP is the substance which is most likely to be the NANC transmitter in the 
intestine and bladder, and thus the purinergic nerve hypothesis was formulated 
(Bumstock, 1972). Since then, considerable evidence has accumulated in 
support of this hypothesis, although there have also been some reports that 
oppose it (Bumstock, 1981).
It was generally believed that each type of autonomic nerve releases only one 
transmitter. In 1976, Bumstock also suggested that some nerve cells store and 
release more than one neurotransmitter. The co-transmission hypothesis is now 
widely accepted and it is recognised that many nerves contain more than one 
transmitter (Bumstock, 1986). There is evidence for the co-release of ATP and NA 
from some sympathetic nerves (Bumstock, 1983; Sneddon & Bumstock, 1984).
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2. ENDOTHELIUM AND MODULATION OF TONE:
The vascular endothelium is the layer of squamous epithelial cells that is in 
direct contact with blood and endothelial cells line the entire circulatory system. 
In addition to its important functions, which include, a: Capillary transport and 
exchange between blood and tissue, b: Regulation of plasma lipids, c: 
Participation in the control of haemostasis, the endothelium modulates the reactivity 
of vascular smooth muscle (Robertson & Rosen, 1978; Vanhoutte et al., 1986). This 
regulatory role involves several mechanisms which include a: The endothelium 
acts as a physical barrier that prevents hormones and other vasoactive agents that 
circulate in blood acting on vascular smooth muscle, b: The endothelium extracts 
and metabolizes or inactivates vasoactive substances such as NA, serotonin and 
kinins and thereby prevents or diminishes their activity in vascular smooth 
muscle; c: The endothelium activates enzymes of plasma constituents such as 
angiotensin-II by converting enzyme; d: The endothelium secretes vasoactive 
agents such as prostacyclin and other inhibitory and excitatory mediators in 
response to vasoactive stimuli (Vanhoutte et al., 1986; Vanhoutte & Liischer, 1986; 
Greenberg & Diecke 1988).
a: ENDOTHELIUM DERIVED RELAXING FACTOR (EDRF):
Furchgott studied the paradoxical finding that acetylcholine (ACh) caused 
vasodilation in vivo but, not in vitro. Furchgott and Zawadzki (1980) discovered
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that ACh-induced relaxation of isolated arteries depends on the presence of 
endothelial cells. Although initially described in the rabbit aorta, it was soon found 
that this is the case in all the isolated arteries from all mammalian species 
tested so far, including man (Vanhoutte & Liischer 1986). The ACh-induced 
vasorelaxation was mediated by muscarinic receptors on the endothelial cells. 
When the endothelium is exposed to ACh it releases a diffusable substance with 
inhibitory effects on vascular smooth muscle. This substance was termed 
Endothelium-Derived Relaxing Factor (EDRF), to differentiate it from known 
vasoactive substances such as prostacyclin and Endothelium Derived Contracting 
Factor (EDCF). In addition to ACh, various substances release EDRF. These include 
adenosine triphosphate (ATP) and adenosine diphosphate (ADP), arachidonic acid, 
the calcium ionophore A-23187, substance P, histamine, platelet activating 
factor, serotonin, thrombin, bradykinin and vasopressin (Furchgott & Zawadzki, 
1980; Griffith et al., 1984; Vanhoutte et al., 1986; Greenberg & Diecke 1988; 
Newby & Henderson, 1990). Some of these substances exhibit 
endothelium-dependent relaxation only or predominantly in some vascular beds and 
not in others. For example, vasopressin causes endothelium-dependent relaxation 
of basilar arteries, but causes contraction in systemic blood vessels (Katusic et 
al,. 1984). Other studies have indicated that substances that release EDRF also 
produce endothelium-dependent hyperpolarisation (Bolton & Clapp, 1986). This 
transient hyperpolarisation appears to be independent of the stimulation of guanylate 
cyclase by EDRF and may be due to activation of smooth muscle Na+/K+ 
-ATPase or K+ -channels (Feletou & Vanhoutte, 1988) by a substance other than 
EDRF (Vanhoutte, 1987). One substance which has been shown to activate K+
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-channels has been termed Endothelium-Dependent Hyperpolarizing Factor 
(EDHF) (Komori & Suzuki, 1987; Komori et al., 1988).
The chemical structure of EDRF has been investigated, despite the problems 
arising from its short half-life ( 6  sec). Many attempts have been made to implicate 
a metabolite of arachidonic acid (AA), arising from cyclo-oxygenation, 
lipo-oxygenation, mono-oxygenation or free radical formation, but these have 
largely been unsuccessful (Furchgott, 1983; Gryglewski et al., 1988). Furchgott 
(1986) first proposed that EDRF is nitric oxide (NO) (cited by Furchgott, 1988), 
and this view has been supported by others (Palmer et al., 1987; Ignarro et al., 
1987; Ignarro, 1990). It has also been reported that the source of NO is L-arginine 
(Ignarro et al., 1987; Collier & Vallance, 1989).
L-arginine is the natural substrate for NO synthase and arginine analogues can act 
as either inhibitors or alternative substrates for this enzyme (Palmer et al., 1988), 
One such analogue, N°-monomethyl-L- arginine (L-NMMA), which was initially 
shown to be an inhibitor of the formation of NO2' and NO3' from L-arginine in the 
macrophage (Hibbs et al., 1987), has been widely used as a tool to study this 
pathway in a variety of biological systems. Blockade of NO synthesis by L-NMMA 
is stereospecific (Stuehr et al., 1989) and is competitively reversed by L-arginine but 
not by D-arginine in all systems so far studied (Collier & Vallance, 1989).
Nitrovasodilators and endogenous NO act by stimulating soluble guanylate cyclase 
(Murad et al., 1978). The effect of NO depends on its site of release. If the 
generator cell is the vascular endothelium, NO (EDRF) released by ACh or 
bradykinin, activates guanylate cyclase in adjacent smooth muscle cells which then 
relax. In addition, NO inhibits adhesion and aggregation of platelets (Collier &
1 4
Vallance, 1989).
b: ENDOTHELIUM DERIVED CONTRACTING FACTOR (EDCF):
In addition to producing EDRF and prostacyclin, the endothelium also releases 
EDCF. It has been shown that removal of the endothelium, depressed the 
contractile responses of canine mesentric veins to ACh (Greenberg & Tanaka, 1982), 
and of canine pulmonary and splenic veins to NA (De Mey & Vanhoutte 
1981,1982 a,b.). Moreover, the contractile responses to substances such as histamine 
were enhanced. Thus, it was suggested that some vasoconstrictor agents (NA and 
ACh) stimulate the release of a vasoconstrictor substance from the endothelium of 
some canine arteries and veins (De Mey & Vanhoutte 1981,1982; Greenberg 
& Tanaka, 1982; Liischer & Vanhoutte, 1986). EDCF(s) are also released from the 
endothelium in response to stretch (Katusic et al., 1986), distension and anoxia (De 
Mey & Vanhoutte, 1983; Rubanyi & Vanhoutte, 1985) and appear to play a major 
role in the facilitation of vascular constrictor responses to other substances rather 
than in initiating contraction. Three classes of EDCF appear to be released by the 
endothelium of blood vessels in response to various stimuli. Rubanyi (1987) has 
classified them as: 1) Arachidonic-derived EDCF (EDCF!); 2)
Polypeptide-derived EDCF (EDCF2) and, 3) Undefined, diffusible EDCF 
(EDCF3) (cited by Greenberg & Diecke, 1988). Recent studies have indicated that 
the endothelium is capable of releasing a highly potent vasoconstrictor substance 
which has been termed endothelin (Yanagisawa etal., 1988). Many substances
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including thrombin, adrenaline and the calcium ionophore A23187, cause the 
release of endothelin from cultured endothelial cells (Yanagisawa et al., 1988). In 
addition, Vanhoutte and Katusic (1988) has suggested that the superoxide anion 
(0 2+) may be responsible for endothelium-dependent contractions in tissue 
such as the dog basilar artery.
SECTION 3: SIGNAL TRANSDUCTION IN VASCULAR SMOOTH MUSCLE:
Vascular smooth muscle tone is ultimately controlled by alterations in the 
cytoplasmic concentration of free intracellular calcium ions [Ca2+]i . In vascular 
smooth muscle, neurotransmitters, and hormones interact with highly selective 
sites at the cell membrane. These receptors recognise such extracellular stimuli 
and discriminate between closely related molecules. Activation of these receptors, 
generates intracellular signals, that mediate the cellular events. The biochemical 
machinery of the plasma membrane translates the complex language of 
extracellular stimuli into a simpler language of ionic, electrical, and chemical 
signals that control intracellular events. This translation process, which 
converts external stimuli into internal chemical signals is called stimulus-response 
coupling (Berridge, 1981; Michel, 1987). Generally, activation of a cell 
surface receptor stimulates a transducer protein which is a guanine 
nucleotide-binding regulatory protein (G-protein), that becomes active upon binding 
of guanosine triphoshate (GTP). The activated G-protein then acts on an 
amplifier enzyme, which releases a second messenger, which in turn activates
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protein kinases, that catalyse a series of biochemical reactions resulting in the 
cellular response. (Michell, 1987).
The major known transmembrane signalling pathways and their second 
messengers in vascular smooth muscle are cyclic adenosine 3 ,5 monophosphate 
(cAMP) and the product of phosphoinositide (PI)-hydrolysis including, 1,2 
diacylglycerol (DAG) and inositol 1,4,5-triphosphate (I1 4 5 P3or IP3), which in 
turn releases Ca2+, from intracellular stores. Cyclic guanosine 3’5’ monophosphate 
(cGMP) is another second messenger that is involved in vascular smooth muscle 
tone modulation.
I. INTRACELLULAR CALCIUM HOMEOSTASIS:
The messenger role of calcium is fulfilled in two ways:
1) Ca2+-calmodulin pathway, which is activated by a transient rise in [Ca2+]; and is 
responsible for the initial phase of the cellular response; and 2) The protein kinase 
C (PKC)-Ca2+ pathway, which is activated by both the rise in [Ca2+]j and DAG, 
which remains in the cell membrane and is responsible for the sustained phase of 
the cellular response (Rasmussen, 1983). Two integrated membrane systems are 
involved in the control of smooth muscle [Ca2+]j. The first is the plasmalemma, 
which is under the control of the membrane potential, and agonists such as 
neurotransmitters, hormones, and autacoids. The second is, the sarcoplasmic 
reticulum, which is controlled by second messengers.
Membranes form a barrier to an approximately 10,000-fold concentration 
gradient of calcium. The extracellular concentration of Ca2+ is normally held at
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approximately 1000 /xM, whereas in the unstimulated cell, [Ca2*]* is 0.1-0.2 /xM 
(Rasmussen, 1983).
II. ROLE OF PLASMA MEMBRANE:
The plasma membrane controls Ca2+ homeostasis by means of Ca2+ 
transporting systems. Typically, these include; A specific ATPase or Ca2+ -Mg2+ 
-ATPase, which is a Ca2+ extrusion pump, that extrudes Ca2+ from the cytosol 
into the extracelluar space, and Na+ /Ca2+ exchange carrier by which 3 Na+ are 
transported for each Ca2+ (Van Breemen & Saida, 1989).
These systems maintain the high Ca2+ gradient across the plasma membrane, 
and keep intracellular Ca2+ at approximately 0.1/xM. Plasmalemmal Ca2+ 
permeability is regulated by Ca2+- channels which include the voltage operated 
Ca2+ -channel (VOCs), that are sensitive to changes in the transmembrane 
potential, and the receptor operated Ca2+ -channel (ROCs) (Bolton, 1979; Van 
Breemen et al., 1986).
Recently, the role of the second messengers that link the receptor to ROCs 
have received attention. It was reported that IP3 releases Ca2+ from platelet-derived 
plasmalemma vesicles, which were Ca2+ loaded through the Na+ /Ca2+ exchange 
(Rengasamy & Feinberg, 1988). Single cation channel activity has been reported 
in T-lymphocytes, loaded with IP3 (Kuno & Gardner, 1987). IP4 has also been 
proposed as the second messenger linking receptors to ROCs (Irvine & Moor, 1986). 
Another possibility is that a-subunits of GTP binding protein (G-protein) are 
involved, as has been shown for muscarinic activation of K+ channels and Ca2+
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channels in other tissues (Brown & Bimbaumer, 1988). A final candidate for 
indirect activation of at least some cation channels is cytoplasmic Ca2+ (Von 
Tschamer et al., 1986).
A third class of non-selective and stretch-sensitive ion channels, that are 
permeable to Ca2+, has been reported in endothelial cells (Lansman et al., 1987).
III. INTRACELLULAR MEMBRANE AND [Ca2+]j STORES:
Other membranes that are involved in Ca2+ homeostasis are the endoplasmic 
or sarcoplasmic reticulum and the mitochondrial membrane, which has a minor 
role (Carafoli, 1987). It has been shown that the mitochondria and the 
sarcoplasmic reticulum (SR) are the main intracellular calcium stores (Chiesi & 
Carafoli, 1986). Other calcium stores have also been suggested. These include 
plasmalemma-bound calcium (Janis et al., 1987), and Ca2+ -buffering proteins 
(Carafoli, 1987). The sarcoplasmic reticulum contains a specific Ca2+-ATPase, 
which is different from that of the plasma membrane (Ebashi, 1958; Hasselbach, 
1961; cited by Carafoli 1987) for uptake of [Ca2+]; from the cytoplasm and like 
plasmalemmal Ca2+ -ATPase, it could be stimulated by cyclic nucleotides cAMP 
and cGMP (Eggermont et al., 1988; Twort & Van Breemen, 1988). Release of 
Ca2+ from the SR membrane occurs as a result of interaction between IP3 and 
its specific receptor (Berridge & Irvine, 1984) which opens cation channels, that 
allow rapid discharge of the SR Ca2+ store. A guanosine nucleotide regulatory 
mechanism also appears to be involved in this receptor-channel coupling system
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(Gill et al., 1986; Saida & Van Breemen, 1987). It has been shown that smooth 
muscle SR contains two separate types of Ca2+ release channel: IP3 - and 
Ca2+-activated channels (Van Breemen, 1990). This view is supported by the 
observation that Ca2+ enhanced the IP3 -induced Ca2+ release from the SR in 
skinned smooth muscle (Ilino, 1987). Mitochondria contain an uniporter, which is 
different from that of the plasma membrane, used for the release of Ca2+ from the 
matrix to the cytosol. Some mitochondria may also contain a Ca2+ /H+ exchange 
system (Carafoli, 1987). Isolated mitochondria from permeabilized smooth muscle 
cells do not take up significant quantities of Ca2+ unless the Ca2+ concentration 
exceeds 5^M (Somlyo et al., 1982; Yamomoto & Van Breemen, 1986). 
Mitochondria therefore become Ca2+ "sinks" only if locally high concentration of 
Ca2+ are achieved, for example during Ca2+ release from the SR or if entry of 
calcium becomes abnormally high during some pathological state, such as 
hypertension. (Yamomoto & Van Breemen, 1986).
IV. TRANSDUCTION PROCESS IN CELL MEMBRANE:
The major signalling membrane systems involving adenylate cyclase (AC) 
and phospholipase C, have unique membrane transduction components that comprise; 
a specific plasma membrane receptor which is the recognition component, a 
regulatory protein which is the transducing component and is a 
guanine-nucleotide dependent (G-protein), and an amplifier component which is a 
catalytic enzyme (Taylor & Merrit, 1986; Potter, 1990). These two systems are 
associated and have important roles in [Ca2+]j homeostasis. The nature of the
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receptors and catalytic enzymes are different in these systems but the G-protein 
is a common mechanism.
A: TRANSDUCING COMPONENT OR G-PROTEINS:
G-proteins function as transducers of receptor signals into effector responses 
(Fig. 1.3). In the adenylate cyclase (AC) pathway there are two G-proteins, 
comprising a stimulatory G-protein or (Gs) and an inhibitory G-protein or (G;). 
These are structurally similar heterotrimers, composed of highly homologous a 
subunits, a, in Gs and in Gb and a 6  and aY subunit (Houslay, 1990). The 15 and 
If subunits are identical in both G-proteins. The Gs protein is localized on the inner 
leaflet of the plasma membrane (Levitzki, 1990). The a-subunits are the larger 
subunits which possess the GTP binding site. The a g subunits are the target for 
ADP- ribosylation by NAD+ which is catalysed by cholera toxin. The subunits 
are the target for ADP- ribosylation by the .toxin of Bordotella pertussis (pertussis 
toxin) but not by cholera toxin (Gilman, 1987; Casey & Gilman, 1988; Levitzki, 
1990). The primary specificity for both the receptor and the target system resides in 
the a subunit (Litosch, 1990). 15 and Y  subunits are smaller subunits that are 
tightly associated with each other as a 15 Y complex (Casey & Gilman, 1988). These 
BY subunits have a role in anchoring the a  subunit (Stemweis, 1986), and in 
promoting GDP exchange on the a  subunit (Fung, 1983; Correze et al., 1987), and 
attenuation of a-mediated events (Katada et al., 1984). Agonist binding to the 
stimulatory receptors (R,) and GTP binding to G, at the a, subunit are both 
required to induce activation of the catalytic unit (C) of adenyate cyclase (AC) to
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Fig. 1.3.
A schematic diagram of G-protein function. The G-protein consists of three subunits (a, 15,7). 
The BY complex acts as an anchor for the a-subunit which couples to the receptor-agonist 
complex and the GDP is replaced by GTP. Then a-subunit dissociate from the receptor and 
interacts with the catalytic unit (C) of the enzyme and activates it. The enzyme (C) is 
deactivated by hydrolysis of GTP to GDP and the a-subunit reunites with the J5Y-complex and 
make a new G-protein.
the cAMP-producing state. The activated state of the system decays 
concomitantly with the hydrolysis of GTP to GDP and Pj at the G, regulatory site. 
Replenishment of Gs with GTP and the continued presence of agonist at the 
receptor allow the system to regain an active or active/deactivation state. This type 
of "ON-OFF" cycle accounts for the properties of agonist- dependent AC 
(Levitzki, 1987; Levitzki, 1990).
In the resting state the G-protein exists as an unattached af f f  trimer, in which 
the GDP is attached to the a-subunit. After interaction of an agonist with 
its receptor, it undergoes a conformational change involving the cytoplasmic
,-f- i—.'u.—e
domain of the receptor, causing it to develop high affinity for aB T/(Spiegel, 
1990). Receptor association with the G protein occurs with the a  subunit, causing 
bound GDP to dissociate and be replaced with GTP (GTP/GDP exchange). The a 
subunit with the attached GTP (a-GTP) dissociates from RT  This state is called 
"ON state" and a-GTP is in the active form of G-protein and interacts with various 
enzymes, ion channel causing activation or inactivation. For example, activation 
of the 8 -adrenoceptor leads to the formation of a-GTP and in turn activation of 
adenylate cyclase, hereby causing production of cAMP. The "ON state " is 
terminated by hydrolysis of GTP to GDP through the GTPase activity of the 
a-subunit. The resulting a-GDP dissociates from the enzyme and combines with CY 
to produce the "OFF state" (Levitzki, 1987; Levitzki, 1990; Rang & Dale, 1991). 
The inhibitory pathway by G{ is similar to Gs. Houslay (1990) indicated that the G; 
mediated inhibition of AC is achieved in two distinct ways. First, by releasing the 
subunits which are identical to the CX subunits of Q  and serve to inhibit 
the dissociation of Gs, and secondly through the action of GTP bound aG{ which
2 2
appears to be capable of interacting with and inhibiting the catalytic unit of AC 
directly. Activation of phospholipase C is also mediated by a G protein (Gplc) 
(Haslam & Davidson 1984; Blackmore et al., 1985). The identity of this G-protein 
(Gplc) has not yet been established (Litosch, 1990). In 1989 Linden & 
Delahunty reported that a bidirectional control similar to that which regulates 
adenylate cyclase, operates on phospholipase C.
Houslay (1990) suggested that at least two distinct G-proteins can couple certain 
rceptors to the stimulation of inositol phospholipids metabolism. While these 
have yet to be identified, one is believed to be capable of being 
ADP-ribosylated and inactivated by pertussis toxin but the other is not.
B: CATALYTIC COMPONENT OF SIGNAL TRANSDUCTION:
1. ADENYLATE CYCLASE AND CYCLIC AMP:
This enzyme has been isolated from the rabbit myocardium, and identified as 
a glycoprotein which spans the plasma membrane (Pfeuffer et al., 1985). This 
enzyme produces the intracellular second messenger (cAMP) through interaction 
with and activation of the catalytic unit with the a-subunit of G protein. The 
catalytic unit of AC is a hydrophobic protein with a single transmembrane spanning 
domain carrying its catalytic site at the cytoplasmic side of membrane (Levitzki, 
1990). This enzyme is controlled by receptors which can either stimulate (RJ or 
inhibit (RJ its functioning (Houslay, 1990). Activation of this enzyme leads to 
conversion of ATP into cAMP.
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2. PHOSPHOLIPASE-C AND PI-RESPONSE:
A primary receptor-mediated event which occurs when cells are stimulated by 
a variety of hormones, neurotransmitters and growth factors (Ca2+ mobilizing 
receptors) is the activation of a phosphoinositide specific phospholipase C 
(PLC). Hydrolysis of PI by PLC results in the generation of the intracellular 
mediators, IP3 and diacylglycerol (DAG) (Fig. 1.2), which respectively promote an 
increase in levels of cytosolic [Ca2+]j and an activation of protein kinase C.(Berridge 
& Irvine, 1984; Abdel-Latif, 1986; Berridge, 1987; Litosch, 1990).
Since PLC is involved in the initiating event of the Pl-response, several studies 
have examined the nature of PLC. At least two kinds of PLC including cytosolic 
and membrane PLC have been reported, and each of these has different 
subtypes (Abdel-Latif, 1986; Litosch, 1990). However, so far five isoforms of PLC 
have been demonstrated (Bowman, 1992). The primary receptor mediated event 
involves stimulation of PLC by the putative G protein (Gplc). This activation may 
occur as a consequence of a conformational change in the enzyme that lowers the 
Ca2+ concentration required for enzyme activation (Litosch, 1990). The elevation of 
[Ca2+]i may increase net inositol phosphate (IP) production either through activation 
of cytosolic PLC or membrane PLC or both. The increase in Ca2+ levels, resulting 
from Ca2+ influx may further stimulate PLC activity. PKC may also regulate 
PLC through phosphorylation (Berridge, 1987; Cobbold et al., 1990; Litosch, 
1990).
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A schematic digram of the phosphoinositol metabolism (Main routes) in Pl-cycle. R =  receptor, 
G =  G-protein. (Adapted from Berridge & Irvine, 1989).;
Inositol lipids or phosphoinositides constitute less than 10% of total 
phospholipids. Phosphatidylinositol (PI) is the major compound, and 
phosphatidylinositol 4-phosphate (PIP), and phosphatidylinositol 4,5 bisphosphate 
(PIP2) which are collectively referred to as polyphosphoinositides (PPI) are 
minor plasma membrane inositol phospholipids (6 -8 % for PI, 1% for PIP, and
0.5 % for PIP2) (Chuang, 1989). Most of PPI and a minor fraction of PI are plasma- 
membrane bound, while most of the PI is in intracellular organelles, especially 
endoplasmic reticulum (ER). Both phosphatidic acid (PA) and myo-inositol, which 
are precursors for PI synthesis, are synthesized from D-glucose. Briefly, 
CDP-diacylglycerol (CDP-DG or CMP-PA), formed from PA and CTP in the 
presence of CTP-PA cytidyltransferase, are key intermediates in Pl-biosynthesis (Fig 
i.2). Biosynthesis of PI from CDP-DG and myo-inositol, via "Pl-synthase" takes 
place at the ER, from which it is transported to the plasma membrane by a 
specific protein, called "Pi-exchange protein". PI can then be sequentially 
phosphorylated by a specific kinase to generate PIP and PIP2, this process takes 
place in the plasma membrane (Abdel-Latif, 1986).
3. GUANYLATE CYCLASE AND CYCLIC GMP:
cGMP is another important intracellular second messenger. Unlike cAMP, which 
is a second messenger at a wide range of receptors, cGMP is a specific 
messenger with an established signalling role in only a few cell types. These 
include intestinal mucosa, and vascular smooth muscle, in which the cGMP-based 
signal transduction mechanism closely parallels the cAMP-mediated signalling
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mechanism (Bourne & Roberts, 1989).
In 1976, cGMP was suggested to be a mediator involved in vascular smooth 
muscle contraction (Diamond & Blisard, 1976). Synthesis of cGMP is catalysed by 
the enzyme guanylate cyclase (GC), from GTP. Activation of GC was observed 
when azide was added to a crude enzyme preparation to inhibit GTPase activity 
(Kimura et al., 1975). Many of the calcium-mobilizing receptors that trigger an 
increase in PI- hydrolysis, stimulate GC to elevate the intracellular level of cGMP 
(Michell, 1975 ; Berridge, 1981; Berridge, 1984).
There are two forms of GC; 1) The soluble (cytosolic) form, and 2) The 
particulate (membrane) form (Waldman & Murad, 1987). The cellular content of 
cGMP is about 10 times lower than that of cAMP. Distribution of these forms of GC 
varies in different tissues. In some tissues, such as platelets (Bohme et al., 1974; 
Glass et al., 1977), GC is predominantly soluble. In other tissues such as intestinal 
mucosa (Kimura & Murad, 1975; Quill & Weiser, 1975), the enzyme is 
predominantly particulate. Activation of soluble GC is of major importance in the 
modulation of vascular reactivity. However, the atriopeptins, stimulate particulate 
GC, exclusively in vascular tissue (Waldman et al., 1984; Winquist et al., 1984). 
Recently it has been reported that GC, like AC is under the control of G-proteins 
(Rang & Dale, 1991). cGMP like cAMP acts by activating specific protein 
kinase (PK), in this case cGMP-dependent protein kinase (PKG). Cyclic nucleotides 
are inactivated by phosphodiesterases (PDEs). Butcher and Sutherland (1962) 
described cAMP PDEs which catalyse the conversion of cyclic 3’ ,5’ , AMP to 
5’ AMP. PDEs are the enzymes that catalyse the hydrolysis of phosphodiesters 
such as cyclic nucleotides and PIP. Cyclic nucleotide PDEs occur as a number
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of isoenzymes, exhibiting distinct kinetic properties, substrate specification and 
cellular localization. Three groups of cyclic nucleotide PDEs are recognised in 
mammals. One is membrane-bound with a high afinity for cAMP, the other two 
forms are cytosolic and are capable of hydrolysing both cAMP and cGMP. After 
separation by DEAE-cellulose chromatography, they have been classified as:
1) cGMP-PDE which has a higher affinity for cGMP than for cAMP, and hydrolyses 
principally cGMP, even at low substrate levels. 2) Ca2+- calmodulin PDE since it 
requires Ca2+ and calmodulin and preferably hydrolyses cGMP ; 3) cAMP-PDE 
which is a specific cAMP PDE (Hidaka et al., 1977; Bowman et al., 1986). In 
recent years, these PDEs have been further subdivided and classified as: I: Ca2+- 
calmodulin dependent, II: Cyclic GMP-dependent, III: Cyclic GMP-inhibited, IV: 
Cyclic AMP-specific, and V: Cyclic GMP-specific (Beavo & Reifsnyder, 1990; 
Nicholson et al., 1991; Bowman, 1992).
Apart from activation of GC by GTPase inhibitors (Kimura et al., 1975), other 
nitrogen-containing compounds including nitroprusside, nitroglycerine, sodium 
nitrate and nitric oxide (NO), activate GC and increase cGMP synthesis in 
vascular and non-vascular smooth muscle (Katsuki et al., 1977; Gruetter et al., 
1981; Axelsson et al., 1982; Axelsson & Anderson 1983). Such substances, 
which mediate vascular smooth muscle relaxation by activating GC and increasing 
intracellular synthesis of cGMP are termed "nitrovasodilators". Relaxation of 
blood vessels by the nitrovasodilators occurs both in the presence and absence of 
an intact endothelium, hence, these agents have been termed 
"endothelium-independent". In contrast, agents such as ACh, histamine, 
bradykinin, the calcium ionophore A23187, ATP, NA, and thrombin require an
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intact endothelium in order to relax blood vessels (Furchgott & Zawadski 
1980; Rapoport & Murad 1983 a,b; Furchgott, 1981 and 1984). These agents 
are therefore termed "endothelium-dependent" vasodilators. In fact, in the absence 
of endothelium some of these agents, become vasoconstrictors, depending on the 
blood vessel and species being tested. It is known that these agents interact with 
specific receptors on the endothelium and cause the synthesis and/or release of 
EDRF (Furchgott & Zawadski 1980; Furchgott, 1984).
SECTION 4. MECHANISMS PRODUCING TONE IN VASCULAR SMOOTH 
MUSCLE
I. CONTRACTION OF VASCULAR SMOOTH MUSCLE:
Contraction of vascular smooth muscle is mediated by any mechanism that 
increases [Ca2+]j. These include mechanisms that cause either Ca2+ influx, such 
as occurs with potassium chloride (KC1), or mobilization of intracellular calcium 
as a result of Pl-hydrolysis and generation of second messengers IP3 and DAG 
(Berridge, 1981; Michell et al., 1981). This bifurcating pathway leads to muscle 
contraction by two mechanisms; 1) IP3/[Ca2+]r  calmodulin pathway; 2) DAG/PKC 
pathway, both of which cause phosphorylation of the contractile proteins.
A: IP3 /[Ca2+]j -CALMODULIN PATHWAY:
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The role of inositol lipids in cellular signalling has been known since the 
initial finding of Hokin and Hokin (1953), who demonstrated the effects of 
neurotransmitters and hormones on phospholipid turnover. They reported that 
phospholipids, later identified as phosphatidylinositol (PI) and phosphatidic acid 
(PA), may play an important part in receptor-mediated cell responses (Hokin & 
Hokin, 1955; 1958). Michell in 1975, first proposed the term "calcium- mobilising 
receptors" for receptors that trigger hydrolysis of PI and in turn release [Ca2+];. 
Michell also observed that the mobilisation of [Ca2+]j induced by a number of 
agonists is prece ded by the breakdown of PI and recognized that it is the 
breakdown of PIP2, rather than of PI that is important. The formation of IP3 and 
IP2 in response to the activation of surface membrane receptors was demonstrated 
by Berridge (1983) and by Streb et al, (1983), who first reported that I1)4(5 - P3 
released calcium from a non-mitochondrial store (ER), in permeabilized pancreatic 
acinar cells. This observation has been confirmed in many other permeabilized 
cell system (Reviewed by Berridge, 1984 & 1987). In particular, it has been 
demonstrated in permeabilized vascular smooth muscle by Yamamoto & Van 
Breemen (1985), in rat aortic smooth muscle, by Hashimoto et al. (1986) in rabbit 
mesenteric artery. The interaction of IP3 with its specific receptor on the 
sarcoplasmic reticulum (SR) opens Ca2+ -channels, which allow the rapid release 
of Ca2+ from SR store (Bingham Smith et al., 1985; Baukal et al., 1985). A 
guanine nucleotide regulatory mechanism also appears to be involved in this 
receptor- channel coupling system ( Saida & Van Breemen 1987; Gill et al., 1986). 
IP3 -induced Ca2+ release from permeabilized rabbit mesentric smooth muscle is 
dependent on the presence of GTP or its non-hydrolysable analogue C2 PP NHp,
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and is inhibited by pertussis toxin (Saida & Van Breemen, 1987). Plasmalemma 
bound Ca2+ has been suggested to be an additional source of Ca2+ (Janis et al., 
1987), and could be released by Pl-hydrolysis during agonist-induced stimulation 
(Saida & Van Breemen, 1984). The rise in [Ca2+]j induced by IP3 from SR can only 
be transitory, and hence it causes the initial phase of contraction (Berridge & 
Irvine, 1984), after a short time (in practice, 1-2 min with a high dose of agonist), 
the plasma membrane Ca2+ -pump should drive the Ca2+ out of the cell, and with the 
intracellular stores now empty, the [Ca2+]i will return to the resting level despite the 
continuing presence of IP3. In fact the Ca2+ levels and contraction usually remain 
elevated as a result of influx of extracellular calcium, through VOCs or ROCs but 
activation of many receptors increases only IP3 and DAG production and it is by the 
inositol phosphate that Ca2+ entry is increased. This is a controversial issue. 
Casteels and Droogmans (1981) suggested that the calcium content of an 
intracellular store may control Ca2+ entry. Kuno and Gardner (1987) suggested 
that IP3 might act on a Ca2+ -channel in the plasma membrane. Another 
possibility is that the receptor mechanism may generate its own channel in the 
form of phosphatidic acid (PA) (Putney et al., 1980; Salmon & Honeyman, 1980). 
The DAG formed by Pl-hydrolysis is phosphorylated to PA, which then acts as 
a calcium ionophore before it is resynthesized back to PI. Another possibility is 
that the Ca2+ enters the intracellular calcium pool directly, by a gap-junction-like 
structure from outside the cell (Merrit & Rink, 1987). Work by Irvine and Moor 
(1986) on sea urchin eggs suggested that IP4 has a role in regulating Ca2+ entry. 
They reported that the Ca2+-releasing action of IP3 is insufficient to activate the eggs 
fully, and that Ca2+ entry due to IP4 is necessary as well. Because IP4 did not
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activate the eggs when injected alone, they speculated that the release of Ca2+ by 
IP3 is a necessary prelude to the action of IP4 . Increase in [Ca2+]; leads to formation 
of the Ca2+-calmodulin complex, which binds to and activates a number of different 
enzyme systems, including myosin light chain kinase (MLCK), and in turn triggers 
contraction through MLC phosphorylation. Relaxation would be induced by 
inactivation of MLCK, following a reduction in [Ca2+]j and dephosphorylation of 
MLC by phosphatase (Morgan et al., 1976; Pato & Adelstein 1980; McCall,
1987).
B: DAG/PKC PATHWAY:
The other major product of PIP2 hydrolysis is DAG, which also has an 
important second messenger function in that it activates C-kinase or protein kinase 
C (PKC) to phosphorylate specific proteins (Takai et al., 1979; Kishimoto et al., 
1980; Nishizuka, 1983). PKC was first found in 1977, in many tissues, 
including vascular smooth muscle (Inoue et al., 1977; Kuo et al., 1980). The usual 
view of PKC is that the enzyme exists in both cytosolic and plasma membrane-bound 
form but with the equilibrium in favour of the cytosolic form in the resting cell 
(Burgoyne, 1989). Protein chemistry and molecular cloning techniques have 
identified at least seven isoforms within a given mammalian species, and it seems 
likely that this is a minimum estimate (Dreher & Hanley, 1988; Nishizuka, 1988; 
Bowman, 1992). The activation of PKC by DAG is a complex process that requires 
Ca2+ and phosphatidylserine as cofactors (Berridge, 1984). DAG is normally almost 
absent from membrane, but is transiently produced from Pl-hydrolysis in response
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to extracellular signals. Kinetic analysis indicates that a small amount of DAG 
dramatically increases the affinity of PKC for Ca2+, and fully activates the enzyme 
without any change in Ca2+levels (Kishimoto et al., 1980; Kaibuchi et al., 1981). 
Activation of the enzyme appears to cause a physical translocation of the enzyme 
from the cytosol into the membrane and this might be the role of Ca2+ (May et al., 
1985; Wolf et al., 1985). PKC exists in vascular smooth muscle (Kuo et al., 
1980), and induces contraction of vascular smooth muscle by phosphorylation of 
MLC at a different site from that of MLCK (Naka et al., 1983; Ikebe et al., 1985; 
Nishikawa et al., 1984; Itoh, et al., 1986). Moreover, it has been shown that the 
activation of PKC is responsible for sustained muscle contraction (Defeo & 
Morgan, 1985; Chatteijee & Tejada, 1986). PKC also could be activated by 
tumour promoting phorbol esters, such as 1 2 -O-tetradecanoylphorbol -13 acetate 
(TPA), which has a molecular structure very similar to DAG, and activates the 
enzyme both in vitro and in vivo (Nishizuka, 1984). Kinetic studies have shown 
that like DAG, phorbol esters dramatically increase the affinity of PKC for Ca2+ so 
that the requirement for activation of enzyme is less than the 0 .1/xM. As a result, 
full activation of PKC occurs without any increase in Ca2+ concentration (Kikawa 
et al., 1986). This enzyme has been shown to have two negative-feedback roles on 
intracellular Ca2+ increase. PKC acts both to inhibit PIP2 -hydrolysis and to 
reduce [Ca2+]; by stimulating the Ca2+ -pump (Berridge, 1987).
II. RELAXATION OF VASCULAR SMOOTH MUSCLE (VSM):
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Relaxation of VSM is mediated by any mechanism that decreases [Ca2+]j. These 
mechanisms include: 1) Inhibition of Ca2+ influx through Ca2+-channels; 2)
Promotion of Ca2+ extrusion through the cell membrane; 3) Phosphorylation of 
MLCK or inhibition of MLCK; 4) Ca2+ -sequestration by activation of uptake 
mechanisms on SR; 5) Inhibition of Pl-response, and in turn reduction of IP3 and 
DAG production ; 6 ) Cyclic nucleotide production.
The most important agents that control vascular relaxation are the cyclic 
nucleotides; cAMP and cGMP, which act through activation of cAMP- dependent 
protein kinase (PKA), and cGMP-dependent protein kinase (PKG), respectively and 
through phosphorylation of targets such as MLCK.
In vascular smooth muscle, elevation of cAMP synthesis and thus vasorelaxation 
occurs in response to 15-adrenoceptor agonists, to PDE-inhibitors and to direct 
activation of AC (Chiesi & Carafoli 1986).
Cyclic AMP has multiple inhibitory effects on vascular smooth muscle including 
phosphorylation and inactivation of MLCK and reduced affinity for 
Ca2+-calmodulin, activation of the Ca2+ - ATPase -pump in sarcolemmal membrane, 
increased Ca2+ extrusion, and enhancement of Ca2+ uptake by activation of Ca2+ 
-ATPase on the SR membrane. (Conti & Adelstein 1981 ; Eggermont et al., 1988; 
Van Breemen & Saida 1989). Moreover, the inhibitory effect of cAMP on VOCs 
has been confirmed by Ousterhout & Sperelakis in 1984.
It has been shown that vascular smooth muscle relaxation induced by both 
endothelium-dependent and independent vasorelaxants is mediated by elevation of 
cGMP (Rapoport & Murad 1983). Moreover cGMP analogues directly relax 
vascular smooth muscle (Lincoln, 1983). Like cAMP, cGMP has multiple
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inhibitory effects on vascular smooth muscle including; stimulation of SR 
Ca2+-pump, (Twort & Van Breemen 1988); stimulation of Ca2+-ATPase in the 
plasmalemma (Twort & Van Breemen 1988); phosphorylation of MLCK (Chiesi 
& Carafoli 1986); and inhibition of Pl-hydrolysis (Rapoport, 1986). However, 
despite various suggestions of different mechanisms to explain the effects of cyclic 
nucleotides on vascular smooth muscle tone, the details of how cyclic nucleotides 
cause vasorelaxation remain unclear. The complex interacting mechanisms that 
regulate tone in vascular smooth muscle are illustrated in Figure 1.4.
SECTION 5. ALTERATION IN MECHANISMS MODULATING TONE IN 
HYPERTENSION:
Essential hypertension has been recognized for 100 years, since Mahomed in 
1881 began to measure systemic blood pressure (cited by Heagerty et al., 1988), 
and define a group of patients whose hypertension was not associated with 
pre-existing renal disease. Later Volhard and his collaborators in 1918 (cited by 
Komer 1982), separated what we know as essential hypertension from the 
hypertension associated with nephritis and other types of parenchymal renal disease. 
Until then, these disorders had all been known together as complications of 
Bright’s disease (Komer, 1982). The modem classification of hypertension into 
primary or essential, and secondary hypertension with known pathological causes 
grew directly from the classification of Vohard and Fahr (cited by Komer 1982).
The elevated arterial pressure in essential hypertension is believed to result
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Fig. 1.4.
A schematic diagram showing the principal mechanisms that modulate tone in vascular smooth 
muscle. The endothelial cell release EDRF (NO) and PGI2, which respectively activate cytosolic 
guanylate cyclase (GC) to produce cGMP, and membrane adenylate cyclase (AC) to produce 
cAMP. AC, unlike GC, is regulated via both excitatory and inhibitory receptors, which control 
the enzyme by activating G-proteins (G( and Gs). NA released from noradrenergic nerves acts 
on oij-adrenoceptors to cause Pl-hydrolysis, which results in the production of IP3 and DAG 
which cause contraction. NA release is regulated via various presynaptic receptors. The tone of 
vascular smooth muscle is the resultant of the opposing mechanisms that cause contraction and 
relaxation.
from an increase in PVR (Bohr & Webb, 1984). Haemodynamically, hypertension 
is the result of changes in the vasculature, which undergoes dramatic structural and 
functional changes.
I. STRUCTURAL CHANGES:
The early work of Bright in 1936 and Johnson in 1868 (Cited by Heagerty et 
al., 1988) demonstrated that walls of arteries were thickened in hypertension. 
Pickering (1939) noted that even after maximal vasodilation, resistance to 
blood flow remained increased in hypertensive pateints, due to the increased wall 
thickness (Cited by Heagerty 1988). The etiology of wall thickening is unknown 
and is a controversial issue. Although most studies suggest that structural 
changes are adaptive responses to the increase in mechanical load, a number of 
publications suggest that other factors (neural, genetic, humoral) contribute to 
morphological alteration in the hypertensive vasculature (Nordborg & Johansson 
1979; Hart et al., 1980; Bell & Overbeck, 1979; Bevan, 1984; Rorive et al., 1986). 
In fact, there may be no conflict between these views since some of these factors 
(neural and humoral) may be the means by which the adaptive response to increased 
load is achieved. Folkow (1978) established that wall thickness not only increases 
vascular resistance by structural encroachment on the lumen and changing 
wall/lumen ratio, but also amplifies all pressor responses caused by vascular smooth 
muscle contraction. Mulvany in 1978 found that at a given transmural pressure, 
relaxed blood vessels of spontaneously hypertensive rats (SHR) had 16% smaller 
lumen diameter and 40% thicker media compared to normotensive vessels. This
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may be an adaptive change, in which the vessel wall thickens in response to the 
increased wall stress, induced by hypertension (Folkow, 1982). The thickness of 
the media in hypertensive vessels is the result of hypertrophy and/or hyperplasia. 
Since vascular smooth muscle cell volume and surface area are increased in 
mineralocorticoid-induced hypertension in rats, it appears that hypertrophy is 
responsible in this case (Friedman et al., 1971). The DNA content of vascular 
smooth muscle from hypertensive rabbit aorta is also increased compared to that 
of control animals (Bevan, 1976). This suggests that the number of smooth muscle 
cells may be increased in some forms of hypertension.
II. FUNCTIONAL CHANGES:
Functional changes in the vasculature in hypertension are extremely variable. 
In some types of hypertension, some vascular segments show altered sensitivity or 
reactivity to certain stimuli, whereas in other types the functional abnormality may 
be different. The alteration and variability do not appear to be related to the 
machinery used to produce the contractile force (i.e. actin and myosin). Several 
studies suggest that the interactions between actin and myosin, and regulatory 
proteins are unaltered in vascular smooth muscle from hypertensive animals 
(Seidel, 1979; Moreland et al., 1982; Nghiem & Rapp 1983; Garwitz MacMahon 
& Paul 1985).
The reported variability is the result of several factors; 1) The primary cause 
of hypertension; 2) The stage of development and the duration of the elevated 
pressure; 3) The animal species examined; 4) The age and sex of the animal; 5)
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The techniques used to study vascular changes; 6) The stimulus employed and 
7) The location of the vascular bed (Bohr & Webb 1984, 1986). However, despite 
this complexity, it has been suggested that the major abnormality in hypertension 
is in the altered properties of the vascular smooth muscle membrane (Bohr & 
Webb, 1988).
A: CHANGES IN SENSITIVITY TO VASOACTIVE AGENTS:
Many studies have examined vascular reactivity in hypertensive blood vessels 
and have found differences in comparison with the corresponding normotensive 
vessels, either in maximum contractility or in sensitivity to different contractile 
and vasorelaxant agonists (for review see Mulvany, 1983; Triggle & Laher
1985).
Numerous reports have provided evidence suggesting that hypertensive vessels 
in various models of hypertension (including human essential hypertension) are 
hyporesponsive or subsensitive to various stimuli (Spector et al., 1969; Shibata et 
al., 1973; Hansen & Bohr 1975; Chaturvedi et al., 1978; Fitzpatrick & Szentivanyi 
1980; Moulds 1980, 1981; Pang & Sutter 1980 Swamy & Triggle 1980). In 
contrast, many reports have shown hypertensive vessels to be supersensitive to 
various stimuli (Bevan et al., 1975; Hermsmeyer, 1976; Lais & Brody 1978; Cohen 
& Wiley 1979; Whall et al., 1980; Webb et al., 1981; Jones et al., 1988; 
Lograno et al., 1989).
Moreover, some investigators including Clineschmidt et al., (1970) and 
Hallback et al., (1971), reported that aortic strips from SHR and normotensive
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rats showed equal sensitivity to vasoactive agents such as NA. Recent 
observations suggest that some of the variability between studies may be due to the 
ability of the endothelium to influence vascular reactivity, by releasing vasoactive 
agents (Vanhoutte et al., 1986).
The majority of observations indicate that hypertension is characterized by 
increased sensitivity to constrictor agonists, whereas vascular responsiveness to 
vasodilator agents is decreased. (Bohr & Webb 1986). However, a conclusive 
answer has not yet been given to the question of the nature of the sensitivity 
alteration that occurs in vascular smooth muscle in hypertension.
B: ENDOTHELIAL LAYER AND HYPERTENSION:
The vascular endothelium changes morphologically and functionally in 
hypertension. In normotensive animals the endothelium consist of a thin layer of flat 
cells. In contrast, in hypertensive animals the cells bulge into the lumen. In addition 
their permeability is increased and the subendothelial tissue is thickened (Vanhoutte 
& Liischer, 1986).
Endothelium-dependent relaxations to ACh, Ca2+ ionophore A-23187 and 
adenosine diphosphate are reduced in SHR rats and Dahl hypertensive rats in 
comparison with normotensive controls (Winquist et al., 1984 ; Liischer et al.,
1986). Furthermore, Vanhoutte and Liischer in 1987 have demonstrated that in the 
SHR, but not in the salt sensitive Dahl rats, ACh caused endothelium- dependent 
contractions. In this experimental model of hypertension, the reduced relaxation 
caused by ACh is due not to the abnormal release of EDRF(s), but rather to the
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concomitant release of an endothelium-derived constrictor factor, perhaps resulting 
from cyclo-oxygenase activity. In other animal models of hypertension, the reduced 
relaxation to ACh could be due to decreased production of EDRF(s), impaired 
diffusion of the relaxing factors from the endothelium to the smooth muscle 
(because of subendothelial thickening as a consequence of the hypertensive process), 
or to a decreased responsiveness of the smooth muscle to EDRF(s) (Collis & 
Vanhoutte 1977; Cheng & Shibata 1980; Konishi & Su 1983; Lee et al., 1987; 
Shirasaki et al., 1988). In arteries of the dog, a-adrenoceptor agonists, adrenaline 
and noradrenaline cause endothelium-dependent relaxation, hence the contractions 
evoked by non-selective adrenergic agonists, in particular, adrenaline and NA, are 
augmented, following removal of the endothelium. Although alterations in 
endothelial cell functioning may be primarily responsible for these changes (Lee 
et al., 1987; Shirasaki et al., 1988), the exact mechanisms underlying them remain 
unclear.
C: CELL MEMBRANE ABNORMALITIES AND INTRACELLULAR CALCIUM 
REGULATION IN HYPERTENSION:
The cell membrane consists of a lipid bilayer with embedded integral proteins 
that serve as receptors, channels, exchangers or active pumps (Carruthers & 
Melchior 1986; Rinaldi & Bohr 1988). The intracellular Ca2+ concentration, which 
is the principal determinant of vascular smooth muscle contraction and relaxation is 
regulated by cell membranes (plasmalemmal and intracellular membranes).
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Observations in both clinical and experimental hypertension, suggest that 
abnormalities may occur in membrane functioning (Doyle & Fraser 1961; Bohr 
& Webb 1988). Contraction of smooth muscle is mediated by activation of 
MLCK by Ca2+-calmodulin. This occurs over a Ca2+ concentration range of
0.1 to 10 fxM as a result of interaction between myosin and actin (Webb & 
Bohr 1981). In addition, Ca2+ -activated, phosholipid-dependent PKC may also 
regulate smooth muscle contraction, and phorbol esters, by mimicking DAG function 
in activating PKC, can induce a slowly- developing contraction without altering Ca2+ 
(Itoh et al., 1986; Rasmussen et al., 1987). Nevertheless the major regulator of 
contraction and relaxation is [Ca2+]j, which is regulated by various mechanisms, 
including: Ca2+ -influx, [Ca2+] mobilization by IP3, and indirect mechanisms, such 
as PKC activation, and Ca2+ decreasing mechanisms, including: Ca2+ extrusion, 
Ca2+ sequestration, cyclic nucleotides elevation. Alterations and abnormality in these 
regulatory mechanisms has been reported in the etiology of hypertension ( Sharma 
& Bhalla, 1988; Dominiczak & Bohr, 1990).
1. CALCIUM INFLUX:
Calcium can enter the cell through specific Ca2+ -channels which are regulated 
by changes in membrane potential or voltage operated channels (VOC), or by 
agonist- activated or receptor- operated channel (ROC) (Sharma & Bhalla, 1988; 
Dominiczak & Bohr, 1990)). In addition to these Ca2+-channels, calcium can enter 
the cell in the resting state through leak channels. Van Breemen and his co-workers 
in 1986 measured Ca2+ influx in the vascular smooth muscle of resistance vessels,
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and reported that in the hypertensive state, Ca2+ entry through all of these 
channels is increased, compared to that of WKY controls. Furthermore Aoki & 
Asano, 1986 found that the Ca2+ -channel activator BAY-K 8644 was more 
effective in eliciting contractions in femoral arteries from SHR than in those of 
WKY. These results point to abnormalities in Ca2+ -channel functioning in 
hypertension.
2. INTRACELLULAR CALCIUM RELEASE:
Intracellular Ca2+ release is mediated by PLC activation through G-proteins and 
IP3 formation and in turn IP3 -mediated Ca2+ release from SR (Abdel-Latif, 1986; 
Berridge, 1987). Since the turnover rate of PI can be regulated by PLC activation 
in response to agonists, it is possible that either the quantity or the activation of this 
enzyme during agonist-receptor interaction may be altered in hypertension. It has 
been demonstrated that the activity of PLC in rat aorta in SHR is almost twice that 
found in WKY rats (Uehara et al., 1988), this increase in PLC is evident as early 
as 4 weeks of age suggesting a causative role in the development and maintenance 
of hypertension. Moreover, a positive correlation between blood pressure and 
PLC activity has been observed (Uehara et al., 1988).
It has been suggested that all of the defects in agonist- mediated Ca2+ -metabolism 
in the hypertensive state can be explained on the basis of a single alteration in the 
plasma membrane at the coupling level, involving G-protein. Although the identity 
of the G-proteins involved in the PLC activation has not been clearly established, in 
several systems it appears to be the inhibitory G-protein (G; or Gr like protein) that
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is involved in inhibiting AC (Berridge, 1987). If indeed Ca2+ mobilizing receptors 
in vascular smooth muscle cells are coupled to Gj then this G-protein may have a 
bifunctional role of inhibiting AC activity, as well as activating Pl-hydrolysis 
(Meyer & Marche 1988). In hypertension there may be increased activation of 
PLC by G-protein, leading to IP3 and DAG production. In addition, activated 
G-protein during sustained agonist stimulation may interact directly with Ca2+ 
channels (ROC and/or VOC) to allow increased entry of Ca2+ (Sharma & Bhalla 
1988).
Alteration in the synthesis of inositol phosphates could occur at the different 
stages in the development of hypertension. In rat aorta from mature SHR, there 
was no significant difference from normotensive controls in the basal or unstimulated 
level of inositol phosphates (Heagerty et al., 1986). However, in 5 week-old SHR, 
IP accumulation was greater than in WKY (Heagerty et al., 1986).
* n *
Increased IP-production has been shown in rat aorta from Stroke-prone SHR 
(Turla & Webb, 1990). These changes occur not only in vasculature but also occur 
in other systems such as the erythrocyte (Koutouzov et al., 1983) and platelets 
(Koutouzov et al., 1987). It has been shown that both resting and 
agonist-stimulated [Ca2+]; is increased in vascular smooth muscle, in platelets and in 
lymphocytes from hypertensive patients and from SHR rats (Erne et al., 1984; 
Bruschi et al., 1984; Losse et al., 1984; Nabika et al., 1985; Cooper et al., 1987; 
Lechi et al., 1987; Meyer & Marche 1988). The second PLC-mediated product 
of Pl-hydrolysis is DAG, which activates PKC and causes contraction of vascular 
smooth muscle by a mechanism that is not fully understood (Rasmussen et al.,
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1987). DAG production is increased in hypertension, and as a result, activation of 
PKC is enhanced.
In arteries from genetically hypertensive rats there is increased sensitivity to 
PKC activators (12-O-tetradecanoyl phorbol- 13-acetate and mezerin) in comparison 
with arteries from normotensive controls rats (Turla & Webb 1987). Furthermore, 
a selective inhibitor of PKC [1-(5-isoquin- olinesulfonyl)-2- methylpiperazine] 
blunts the enhanced sensitivity to serotonin in arteries from SHR (Bohr & Webb
1988). Also, increased PKC activity in caudal artery and mesenteric artery from 
SHR has been reported (Turla & Webb 1987; Mackay & Cheung 1987; Bendhack 
et al., 1988 ).
Recently it has been demonstrated that PKC increases protein 
phosphorylation of specific proteins during sustained contraction (Rasmussen et al.,
1987). PKC can also activate potential-operated Ca2+ -channels in smooth muscle, 
thereby elevating [Ca2+]; (Fish et al., 1988). It is therefore possible that increased 
activation of PKC could produce larger contractions of vascular smooth muscle in 
SHR through direct phosphorylation of the contractile proteins as well as activation 
of Ca2+ influx through VOCs.
3. CALCIUM EXTRUSION AND SEQUESTRATION:
Active Ca2+ pumps (ATP-dependent) which are located in the sarcoplasmic 
reticulum (calmodulin-independent) and plasmalemma (calmodulin-independent) are 
responsible for maintaining Ca2+- homeostasis and for returning [Ca2+]{ to the 
resting level after contraction (Van Breemen et al., 1986). Sodium-calcium
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exchange has also been proposed as an additional Ca2+ extrusion mechanism (Ashida 
& Blaustein 1987). Any decrease in the activity of these mechanisms would lead to 
an increase in [Ca2+]; . There is some evidence that this may occur in 
hypertension. For example, a decrease in the ATP-dependent Ca2+ uptake by 
microsomal and plasma membrane-enriched fractions from vascular smooth muscle 
and erythrocyte membranes has been demonstrated in SHR (Bhalla et al., 1987; 
Rinaldi & Bohr, 1988).
Moreover, active calcium extrusion was reduced in mesenteric arteries from 
SHR and animals with mineralocorticoid-induced hypertension (Kwan et al., 1979). 
The calmodulin sensitivity of the SHR plasma membrane Ca2+ pump is decreased 
in hypertension. (Rinaldi & Bohr, 1988) and the role of sodium-dependent calcium 
efflux (Na+ /Ca2+ exchange) was significantly greater in heart sarcolemmal vesicles 
from SHR than in those from WKY (David-Dulfilho et al., 1986). In mesenteric 
artery, it has also been shown that calcium uptake by sarcolemmal vesicles from 
SHR and WKY was dependent upon sodium loading. The level of activity of 
the Na+/Ca2+ exchange was greater in membrane vesicles from SHR (Matlib et al., 
1985).
D. CYCLIC NUCLEOTIDE ALTERATIONS IN HYPERTENSION:
Cyclic nucleotides serve as second messengers, which translate the action of 
hormones and neurotransmitters at their receptors into biochemical events in target 
cells. Cyclic nucleotides therefore affect important regulatory mechanisms that 
modulate vascular smooth muscle tone by regulating [Ca2+]; homeostasis (Chiesi
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& Carafoli 1986; Carafoli, 1987). Abnormalities in cyclic nucleotide metabolism 
may be involved in hypertension.
Three possible abnormalities of cyclic nucleotide metabolism have been identified 
in hypertension. These include increased cGMP/cAMP ratio (Amer et al., 1975), 
depressed basal adenylate cyclase (AC) activity (Ramanathan & Shibata 1974), 
and a reduced ability of AC to be stimulated (Triner et al., 1975). The first 
hypothesis was based on the Yin-Yang theory of cyclic nucleotide action. There 
is evidence that the cGMP/cAMP ratio is elevated in aorta from SHR, and in 
aorta of rats with mineralocorticoid-induced hypertension (Amer et al., 1975).
The increased cGMP/cAMP ratio was initially thought to support the Yin-Yang 
theory of cyclic nucleotide action. However, now the significance of these 
observations is unclear since it is known that cGMP like cAMP, is a vasodilator, 
whereas previously it was thought to be involved in contraction.
Ramanathan & Shibata in 1974 demonstrated that the levels of cAMP were lower 
in blood vessels of young SHR before they developed hypertension. Alteration in 
cAMP metabolism may therefore be a primary event in the development of 
hypertension. These workers also showed that unstimulated levels of adenylate 
cyclase were significantly lower in aorta from SHR in comparison with normotensive 
controls.
Other workers have shown that the basal level of AC and cAMP in aorta of SHR 
do not differ from controls (Triner et al., 1975; and Klenerova et al., 1975). 
However, the concentration-response curve to isoprenaline in SHR aorta was shifted 
to the right of that in normotensive controls, so that higher doses of isoprenaline
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were required in aorta from SHR to produce the same increase in cAMP formation 
as occurred in control aorta.
Most investigators have reported a decrease in cAMP production and a decreased 
vascular relaxation in response to B-adrenoceptor agonists in blood vessels from SHR 
in comparison with normotensive controls (Triner et al., 1975; Cohen & Berkowitz 
1976; Godfraind & Dieu 1978; Asano et al., 1982; Silver et al., 1985). This 
decreased B-adrenoceptor-mediated relaxation that occurs in hypertension, may 
reflect diminshed activity of the stimulatory G-protein (Gs) in vasculature from 
SHR (Asano et al., 1988).
Recently, after the identification of cGMP as a mediator of vasorelaxation, there 
have been several reports of decreased cGMP levels in hypertension (Lee et al., 
1987; and Shirasaki et al., 1988).
The role of the endothelium and its ability to release EDRF have been examined 
in hypertension. It appears that the spontaneous and/or drug-induced release of 
EDRF is reduced in hypertension and this is reflected in a decrease in cGMP 
formation (Otsuka et al, 1988). In contrast, it has been shown that in aorta from 
SHR, the activity of cGMP-dependent protein kinase (PKG) is elevated (Coquil 
et al., 1987).
From the available evidence, it is apparent that no consistent pattern emerges to 
link changes in cyclic nucleotides metabolism with hypertension. The role of cyclic 
nucleotide in hypertension is complex and remains to be clarified.
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AIM OF STUDY:
The aim of this study was to examine the mechanisms that regulate tone in 
isolated blood vessels from normotensive and hypertensive rats.
In particular, this study sought to determine whether there was any difference in the 
responsiveness to vasoconstrictors and vasorelaxants or in the corresponding 
coupling mechanisms in isolated blood vessels from spontaneously hypertensive rats 
(SHR) and from normotensive Wistar Kyoto (WKY) controls.
This study investigated:
1) The mechanical responses of isolated segments of blood vessels from Wistar, SHR 
and WKY rats to vasorelaxants, which produced their effects by different 
mechanisms.
2) The biochemical responses, including changes in the levels of second messengers 
(IPs, cAMP and cGMP) involved in contraction and relaxation and alteration of these 
second messengers in vasculature from SHR rats.
3) The interaction between these second messengers, which are involved in 
regulating the tone of vascular smooth muscle.
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CHAPTER TWO
METHODS & MATERIALS
METHODS AND MATERIALS
METHODS:
Experimental animals:
In this study, adult male Wistar rats (200-300g), normotensive Wistar Kyoto 
(WKY), and Spontaneously Hypertensive Rats (SHR), were used. All animals were 
housed in a controlled environment, under conditions of a circadian cycle of 
light and dark (Light: 6:30-18:30 hrs). Rats were allowed tap water and food 
(Labsure CRM diet) ad libitum. The ambient temperature was maintained 
between 18-22°C.
Dissection of aorta:
Rats were killed by stunning and exanguination. The chest was opened along 
the midline and the thoracic cavity exposed. The lungs, inferior vena cava and 
oesophagus were excised revealing the descending thoracic aorta attached to the 
distal wall of the thoracic cavity. The aorta was removed from the thoracic cavity 
and cleaned of all adhering fat and connective tissue and placed in a petri dish 
containing cold Krebs physiological buffer, which was originally described by 
Krebs and Henseleit (1932). This solution had the following composition; (mM): 
NaCl, 118.5; KC1, 4.75; CaCl2, 2.5; MgSO4.7H2O,1.0; KH2P04,1.2; NaHC03, 
25.0; Glucose, 22.2.
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RECORDING OF MECHANICAL RESPONSES OF TISSUES IN ORGAN
BATHS:
I) Preparation of aortic rings:
The aorta were cut into rings (2-3 mm in length), weighed and suspended in 
25 ml organ baths between two stainless steel wire hooks and attached to the 
transducer by a cotton thread under a resting tension of 2g.(Fig.2.1). Care was 
taken at all times to protect the endothelium from damage. The tissue were 
bathed in Krebs bicarbonate buffer at 37°C and gassed continuously with a 
mixture of 95% 0 2/5% Co2. Isometric tension was recorded using a Statham force 
displacement transducer and was displayed on a Grass polygraph (Model 7 PCPB). 
Measurement of isometric tension was achieved when the applied tension as the 
opposing force exceeded the tension developed by the tissue, without over­
stretching the muscle fibres. A resting tension of 2g was applied to the aortic rings 
and this exceeded the tension developed by the tissue. The tissues were allowed 
to equilibrate for 60 minutes prior to the start of experiments. During this time 
the resting tension was maintained at 2g and the tissues were washed 2-3 
times. This equilibration time was necessary to allow the re-establishment of ion 
concentration gradients and metabolic processes, following dissection of the 
tissue from the animal.
II) Preparation of tail artery rings and segmentsfor perfusion:
Rats were killed in the normal manner. The tail with its skin were removed. The
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Set up for recording of mechanical (Tension) responses of aortic rings. A similar apparatus 
was used for mechanical recording of tail artery rings.
tail artery was located, and dissected out and placed in a petri dish containing 
oxygenated cold Krebs buffer. From each artery four segments were obtained, two 
(2-3 cm) for perfusion pressure recording and two (3-4 mm) for isometric 
tension recording. Segments for perfusion were double cannulated with polythene 
cannulae. The upper cannula was connected with silicone tubing to a reservoir 
containing Krebs buffer. The lower cannula was connected to overflow tubing (Fig. 
2.2). The cannulated artery segments was then placed in an organ bath (25 ml) 
containing Krebs buffer (37° C, gassed with 95% O2/ 5% C 02). The tail artery 
segment was perfused with Krebs buffer (or drug solution) at a constant rate of 1 
ml/min by means of a Watson-Marlow constant flow pump. The preparation was 
allowed to equilibrate by being perfused with Krebs buffer for 90 minutes prior to 
examining the effects of drugs. The resistance of the tail artery to perfusion was 
measured by a Statham pressure transducer and displayed on a Grass polygraph. 
Each artery segment used for tension recording was weighed and suspended 
between stainless steel hooks (0.15 mm diameter) in an organ bath (25 ml) 
containing Krebs buffer. 1 g of tension was applied to each ring and the preparation 
was allowed to equilibrate for 90 minutes before any experimental work was 
carried out.
Ill) Removal of endothelium:
In some experiments, the endothelium was removed mechanically from aortic 
rings by gently rubbing the intimal surface with stainless steel forceps. 
Removal of, or damage to the endothelial cells was confirmed by the inability of 
acetylcholine to relax precontracted aortic rings treated in this manner (Furchgott
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Set up for recording perfusion pressure responses in perfused tail artery segments.
& Zawadzki, 1980). In preliminary experiments, the successful removal of 
endothelium was confirmed by light microscopy (Fig. 2.3).
IV) Addition of drugs:
All drugs were added to the bath in volumes not exceeding 0.3ml, and the drug 
concentration was expressed as the final dilution in the organ bath. Cumulative 
concentration-response graphs were obtained for each contractile agonist and (in 
the presence of a submaximal concentration of a precontracting agonist) for each 
vasorelaxant. The degree of smooth muscle relaxation induced by each vasodilator 
was expressed as a percentage (%) of the maximum contraction to the contractile 
agent (EC50 or EC75 concentration).
In general, drugs were dissolved in 0.9% of saline to give the required 
concentration. Forskolin was dissolved in dimethylsulfoxide (DMSO). The 
concentration of DMSO in the organ bath and in incubation tubes was 0.05% 
V/V. In these experiments the vehicle was used as the control.
MEASUREMENT OF PHOSPHATIDYL INOSITOL HYDROLYSIS:
Products of PIP hydrolysis were measured using a modified version of the 
method of Akhtar & Abdel-Latif (1986), by incorporation of 
myo-(^H)-inositol into the Pl-cycle. Inositol phosphates were extracted and 
separated by ion exchange chromatography.
Plastic pipette tips (5ml) were used as chromatography columns. The tips of 
these were plugged with a piece of glass wool. Ion exchange resin 
(Dowex-AGlx8, Formate form, 100-200 mesh), was washed 4-5 times and 1 ml
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of resin suspension was added to each column. Columns were prepared by 
washing with 15 ml of ammonium formate (2.4M), followed by 15-30 ml of 
distilled water. After using the columns, the resin could be regenerated by washing 
the columns with ammonium formate (2.4M, 15ml).
Aortic rings were prepared as previously described. The aorta was transferred 
to ice-cold Krebs buffer, then the aorta was cut into rings (3mm), which were 
washed with ice-cold Krebs buffer 2-3 times. In each experiment some randomly- 
selected rings were weighed and the mean weight of these rings was used in each 
experiment to calculate the results.
The aortic rings were preincubated in Krebs buffer, bubbled with 95 %02 /5 %Co2 
for 15-30 minutes in a shaking bath at 37°C for equilibration. All steps of the 
experiment before termination were performed in a shaking water bath. The rings 
were then transferred into 20ml glass vials containing 2ml of Krebs buffer, 
containing 8/xCi/ml of myo-^HHnositol in which they were incubated for 2.5-3 
hours. After the incubation the excess radioactivity was washed off with 
oxygenated Krebs buffer (37°C), and each 3mm ring was placed into a plastic 
insert tube containing 280/ri of Krebs buffer (37°C), and 10/xl of lithium chloride 
(LiCl) (lOmM), to prevent the metabolism and breakdown of inositol phosphate, 
to myo-inositol (Berridge et al., 1982). As is shown in Fig. 2.4 the presence of 
the LiCl significantly increased the amount of labelled IPs in comparison with 
controls, which were incubated without LiCl. In experiments with vasodilators, 
the LiCl was added 5-10 minutes after adding the vasodilators and 1 minute 
before adding the vasoconstrictor (Rapaport, 1986). When LiCl was added prior to 
the vasorelaxants, the results were not different with controls. This may be due to
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Effect of lithium chloride (LiCl) on NA-induced Pl-hydrolysis in aortic rings from Wistar 
rats. Pl-hydrolysis was monitored by measuring the levels of ffQ-inositol phosphates. NA 
(6 .2x10^) significantly increased Pl-hydrolysis above the control (CTL) level. (** 
p<0.05, *** p<0.001). This effect was significantly.greater in the presence of LiCl 
(lOmM), both in control (basal) and in NA-stimulated' tissues. ( + +  p<0.05, +  +  +
p<0.001). Results are mean ±  s.e.mean. (n=8).
breakdown or inhibition of the Pl-cycle which seems to be a prerequisite for 
synthesis of cGMP. Stimulation of the Pl-hydrolysis was started by adding 10/ri 
of agonist to the rings in each tube and incubating the rings for 45-60 minutes at 
37°C. During this period the rings were oxygenated. The reaction was then 
terminated by the procedure of Berridge et al. (1982) and Fox et al. (1987), by 
adding a mixture of chloroform : methanol (2ml; 1:2; V/V). The rings were 
homogenised using Potter-Elvehjem glass/glass tissue homogenizers and were 
transferred into centrifuge tubes. Subsequently, more chloroform (0.63ml) and 
distilled water (1.26ml) were added to form two layers, and the tubes were 
centrifuged at 2000xg for 5 minutes at 0° C to separate the aqueous and organic 
phases. The aqueous layer was added to the anion exchange chromatography 
columns. The columns were eluted sequentially with 20ml of distilled water to 
remove the excess myo-(3H)-inositol and 15ml of 50mM of ammonium formate to 
remove glycerophosphoinositides, and eventually total myo-^PTHnositol phosphates 
were collected by washing with 8ml of a mixture of ammonium formate (M) and 
formic acid (0.1 M). 10 ml of scintillation liquid was added to a 2ml aliquot of each 
sample and the radioactivity was counted in a liquid scintillation counter 
(Packard 2000 CA Tri-carb). Generally, the total amount of IPs was measured in 
these experiments. The results were calculated and expressed as disintegrations per 
minute (d.p.m.) per mg of tissue wet weight.
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MEASUREMENT OF CYCLIC GMP:
I) PREPARATION OF TISSUE:
Aortic rings were prepared as previously described for Pl-measurement, 
and placed in a petri dish containing ice-cold Krebs buffer. Each ring was 
mounted on a stainless steel wire hook, and transferred to a flask containing warm 
and oxygenated Krebs buffer, and preincubated for 15-20 minutes for 
equilibration. The rings were then transferred to the vials containing Krebs buffer. 
Drug was then added to the rings in the vials and incubated for an appropriate 
amount of time, after which they were immediately frozen in liquid nitrogen 
this final step was carried out in less than 2 seconds.
II) EXTRACTION OF cGMP:
The frozen aortic rings were deproteinised by extraction in trichloroacetic 
acid (TCA) (1.6ml; 5% W/V). After a period of 2 hours, the rings were detached 
from the wire hooks, re-immersed in TCA and hand homogenised using 
Potter-Elvehjem glass-glass homogenisers. The tissue homogenates were then left 
for a further 18 hrs. at 4°C. Homogenisation broke down the tissue structure and 
increased the surface area across which the TCA could permeate. Homogenisation 
therefore facilitated extraction of cGMP. Morrison (1988), has shown that 
homogenisation of aortic rings during acid extraction significantly increased the 
recovery of cGMP. The samples were vortex-mixed and centrifuged (lOOOxg, 5 
mins., 4°C) to remove any non-acid-soluble tissue components. The cGMP content 
of a fraction of the supernatant (400/d) was extracted by washing four times with
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three volumes of water-saturated ether. Any remaining ether was evaporated by 
placing the sample tubes in a water bath at 80°C for 2 minutes. The samples 
(300 pi) were neutralised with sodium acetate buffer (100/d, 200mM, pH 6.2), 
vortex-mixed and stored at 4°C until required.
Ill) RADIOIMMUNOASSAY:
Tissue cGMP levels were measured using a commercially available cGMP kit 
(Amersham International, UK). The assay was based on the competitive binding 
between unlabelled cGMP and a fixed quantity of the tritium-pH]-labelled cyclic 
nucleotide to an antiserum which had a high specificity and affinity for cGMP. 
Cyclic GMP standard concentrations (0.5-8 pmoles/100/d) were prepared in 
Tris/EDTA buffer (50mM ; pH 7.5). samples of both standard and unknown 
tissue concentrations of cGMP (100/d) were acetylated by the addition of a 
freshly-prepared mixture of acetic anhydride and triethylamine, 1:2 by volume 
(5/d) (Frandsen and Krishna, 1976). The samples were immediately 
vortex-mixed. This acetylation process has been shown to increase the sensitivity 
of the assay (Morrison, 1988). [3H]-labelled cGMP (50/d) was then added to 
each sample, followed by anti-cGMP antiserum (50/d). Samples were 
vortex-mixed and incubated for 16h. at 4 C. Following this incubation, ice-cold 
ammonium sulphate (1ml) was added to each sample and then mixed. The samples 
were allowed to stand for 5 minutes after the addition of ammonium sulphate to 
the last sample and before centrifuging (lOOOxg, 5 min, 4°C). The supernatant 
was decanted and the assay tubes were inverted on a paper tissue to drain. Cold 
distilled water (1.1ml) was then added to each tube, which was vortex-mixed
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until the precipitate had dissolved. Samples (1ml) were transferred from the assay 
tubes to plastic counting vials containing scintillant (Ecosint, 10ml), and antibody 
bound pH]- cGMP was measured by counting for 5 minutes in a Packard liquid 
scintillation counter.
A standard calibration curve was obtained in each experiment and plotted as 
radioactivity bound (d.p.m.) against concentration of cGMP (Fig. 2.5). The 
concentrations of cGMP in unknown samples (100/xl) were determined by 
reference to the calibration curve. The concentration of cGMP in the original 
sample (1.6ml) was expressed in pmol.mg'1 of tissue, and was calculated using 
the following method:
1) Concentration of cGMP in 100/xl (from 1.6ml of total volume) multiplied by 
16 gives the concentration of cGMP in the sample tube (pmol.tube1).
2) Concentration of cGMP in sample tube divided by weight of aortic ring (mg) 
gives concentration of cGMP per weight of tissue (pmol.mg'1).
MEASUREMENT OF CYCLIC AMP:
I) PREPARATION OF TISSUE:
Aortic rings were prepared as for PI and cGMP-measurement, and placed in 
a petri dish containing ice-cold Krebs buffer. Each ring was mounted on a stainless 
steel wire hook, and transferred to a flask containig warm, oxygenated Krebs 
buffer, and preincubated for 15-20 minutes for equilibration. The rings were then 
transferred to the vials containing Krebs buffer and the drug was added to the
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Fig.2.5.
Standard calibration curve for known concentrations of cyclic GMP, measured by 
radioimmunoassay. The ability of cyclic GMP to compete with (3H)-cyclic GMP for binding 
to specific anti-cyclic GMP antiserum was measured (see text for details). C0 is the d.p.m. 
bound in the absence of unlabelled cGMP, and Cx is d.p.m. bound in the presence of 
standard unlabelled cGMP. The straight line is a regression line fitted by computer. Points 
[ are means. (n=10).
rings in the vials and incubated for an appropriate time and then immediately frozen 
in liquid nitrogen. This step was carried out in less than 2 seconds.
II) EXTRACTION OF cAMP:
The frozen aortic rings were deproteinised by extraction in TCA (1.6ml; 5% 
W/V). After a period of 2 hours, the rings were detached from the wire hooks, 
re-immersed in TCA and as in the cGMP extraction, hand homogenised using 
Potter-Elvehjem glass-glass homogenisers. The tissue homogenates were then left 
for a further 18 h at 4°C. Homogenisation broke down the tissue structure and 
increased the surface area across which TCA could permeate. Homogenisation 
therefore facilitated extraction of cAMP. The samples were vortex-mixed and 
centrifuged (lOOOxg, 5min, 4°C) to remove any non-acid-soluble tissue 
components. The cAMP content of a fraction of the supernatant (400/ri) was 
extracted by washing four times with three volumes of water-saturated ether. Any 
remaining ether was evaporated by placing the samples tubes in a water bath at 
80°C for 2 minutes, and stored in 4 C° until required.
III): RADIOIMMUNOASSAY:
Tissue cAMP levels were measured using a commercially available cAMP kit 
(Amersham International, UK). The assay was based on the competitive binding 
between unlabelled cAMP and a fixed quantity of the tritum- [3H]-labelled cyclic 
nucleotide bound to an antiserum, which had high specificity and affinity for 
cAMP.
Cyclic AMP standard concentrations (1-16 pmoles/50/ri) were prepared in
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Tris/EDTA buffer (50mM , pH 7.5). pH]-labelled cAMP (50/xl) was then added 
to each (50/xl) sample, followed by cAMP binding protein (100/xl). Samples 
were vortex-mixed and incubated for 16h at 4°C. Following this incubation, 
ice-cold charcoal reagent, was added to each sample and then briefly vortex-mixed. 
The tubes were replaced in an ice bath or refrigerated centrifuge for 5 minutes. 
The samples were centrifuged (lOOOxg, 5 min, 4°C) to sediment the charcoal which 
was used to separate the protein bound-cAMP from the unbound nucleotides by 
absorption of the free nucleotide on to it. The tubes were centrifuged for not 
less than one minute and not more than 6  minutes after addition of the charcoal to 
the last tube in a batch. Then, without disturbing the sediment, 200/xl of 
supernatant were removed and placed in scintillation vial containing 1 0 ml of 
scintillant. pH]-cAMP was measured by counting the radioactivity in each sample 
for 5 minutes in a Packard liquid scintillation counter. Standard calibration 
curves were obtained and plotted as C0 /Cx against concentration of cAMP where 
C0 and Cx represent the amount of pH]-cAMP bound in the absence and 
presence of unlabelled cAMP respectively (Fig. 2.6).
The concentrations of cAMP in unknown samples (50/xl) were determined 
by reference to the calibration curve. The concentration of cAMP in the original 
sample (1 .6 ml) was expressed in pmol.mg' 1 of tissue and calculated using the 
following method:
1) Concentration of cAMP in 50/xl multiplied by 32, gives concentration of 
cAMP in sample tube (pmol.tube1).
2) Concentration of cAMP in sample tube divided by weight of aortic rings (mg), 
gives concentration of cAMP per weight of tissue (pmol.mg’1).
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Standard calibration curve for known concentrations of cyclic AMP, measured by 
radioimmunoassay. The ability of cyclic AMP to compete with (^H)-cyclic AMP for binding 
to specific anti-cyclic AMP antiserum was measured (see text for details). C0 is the d.p.m. 
bound in the absence of unlabelled cAMP, and Cx is dpm bound in the presence of standard 
unlabelled cAMP. The straight line is a regression line fitted by computer. Points are means. 
(n = 1 2 ).
MEASURMENT OF BLOOD PRESSURE:
The systolic blood pressure were measured in conscious animals by the tail-cuff 
method. The rats were placed in a warming chamber at 37° for 15 minutes prior to 
measuring the blood pressure. This caused vasodilation of the tail artery and 
facilitated detection of the pulse. The rats were then restrained in a cloth bag. 
An inflatable cuff was placed around the base of the tail and a pressure transducer 
placed distal to the cuff. The signal detected by the pressure transducer was 
displayed on a calibrated storage oscilloscope. The cuff was inflated by a motor 
driven piston. The point at which the tail artery pulse stopped, due to occlusion 
of the vessel, showed the systolic blood pressure.
MATERIALS:
The following drugs and reagents were used in this study:
Noradrenaline bitartrate (Sigma), acetylcholine chloride (Sigma), sodium
nitroprusside (Analar), prazosin hydrochloride (Pfizer), myo-pH]-inositol
(Amersham Int.), TCA (B.D.H. Analar), propranolol hydrochloride (Sigma), 
potassium chloride (Koch-Light), theophylline (Sigma), isobutylmethylxanthine 
(Sigma), forskolin (Sigma), 8 -bromo-cAMP (Sigma), 8 -bromo-cGMP (Sigma), 
isoprenaline (Sigma), salbutamol (Sigma), propranolol hydrochloride (Sigma), 
nifedipine (Sigma), ammonium formate (B.D.H., Analar), formic acid (B.D.H., 
Analar), chloroform (B.D.H., Analar), methanol (B.D.H., Analar), cyclic AMP 
and cyclic GMP assay kit (Amersham, UK).
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STATISTICAL ANALYSIS OF RESULTS:
Results were expressed as means ±  standard error of the mean (s.e.mean), 
and n= number of observation.
Student’s t-test was used to test the significance of differences between means. 
Probability values of less than p<0.05 were taken as being significant.
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CHAPTER THREE
RESULTS
RESULTS:
The experimental results are shown in Figures 3.1 to 3.60, which follow page 70.
SECTION 1: MECHANICAL RESPONSES TO VASOCONSTRICTORS AND 
VASORELAXANTS IN AORTIC RINGS FROM WISTAR RATS.
The aim of this series of experiments was to examine the effects of 
vasoconstrictors, whose mechanismsof action were either receptor-mediated, such 
as noradrenaline (NA) or the result of depolarisation (KC1). These experiments 
also examined the effects of vasorelaxants, whose mechanisms of action 
were either endothelium-dependent, such as acetylcholine (ACh) or 
endothelium-independent, such as sodium nitroprusside (SNP), isoprenaline (ISO), 
forskolin (FOR) and isobutylmethylxanthine (IBMX). Two parameters were 
measured in these experiments. These were (i) the isometric tension developed in 
isolated aortic rings in response to vasoconstrictors; and (ii) the degree of 
relaxation produced by vasorelaxants in aortic rings that had been precontracted 
with a vasoconstrictor.
PART 1: Preliminary experiments in isolated aortic rings from Wistar rats.
NA (10'10-3xl0'7 M) caused concentration-dependent contractions in aortic rings 
(Fig. 3.1). At concentrations higher than 10-7 M, responses to NA decreased with 
increasing concentration. KC1 (lO'MO^M) also caused concentration-dependent
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contractions but these cjcurred over a narrow concentration range (Fig. 3.3), which 
was higher than that required to produce contractions to NA (Fig. 3.4).
The endothelium-dependent vasorelaxants ACh (3xl0'9 -3x1 O'6 M) relaxed 
aortic rings that had been precontracted with NA (EC75= 3x1 O'8 M) (Fig. 3.5). The 
endothelium- independent vasorelaxant, SNP (10' 10 -3x1 O'6 M) also relaxed aortic 
rings that had been precontracted with NA (3x1 O'8 M) (Fig. 3.6). SNP was 
more potent than ACh and the maximum inhibition (100%) produced by SNP 
(3xl0 8 M) was greater than that (80%) produced by ACh (3x1 O'6 M) (Fig. 3.7).
ISO (3xl0 10 -10'7 M) caused concentration-dependent vasorelaxation of aortic 
rings that had been precontracted with NA (3x1 O'8 M) (Fig. 3.8). The direct 
activator of adenylate cyclase, forskolin (10'10-10*7 M) (Fig. 3.9) and the 
phosphodiesterase inhibitor, IBMX (3x1 O'6-10^ M) (Fig. 3.10), also relaxed aortic 
rings that had been precontracted with NA (3x1 O'8 M). The relaxation produced by 
IBMX suggests that there was a basal synthesis of cyclic nucleotides in the isolated 
aortic rings that had been precontracted with NA.
PART 2: Mechanical responses to vasoconstrictors and vasorelaxants in
aortic rings from SHR and WKY control rats:
NA (1010-10‘5 M) caused concentration-dependent contractions in aortic rings 
from SHR and WKY control rats. Over the entire concentration range, 
responses to NA were smaller in rings from SHR than^those obtained in rings from 
WKY control rats (Fig. 3.14). KC1 (3xl0'3-8xl0'2 M) also caused 
concentration-dependent contractions in aortic rings from SHR and WKY rats.
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Again, over the whole concentration range, responses to KC1 were smaller in 
rings from SHR than were those obtained in rings from WKY controls (Fig. 
3.15). These results indicate that vasculature from SHR was less sensitive to 
vasoconstrictors than was that from WKY controls.
ACh (3xl0'9-10'6 M) relaxed isolated rings that had been precontracted with 
NA (5.6xld9 M) (Fig. 3.16). The capacity of ACh to relax aortic rings was 
similar in rings from SHR and WKY rats (Fig. 3.16). In contrast, responses to 
SNP were different in rings from WKY control rats. At low concentrations, 
inhibitory responses to SNP were smaller in rings from SHR than those obtained 
in rings from WKY control rats, but responses to high concentrations of SNP, were 
larger in rings from SHR than were those obtained in rings from WKY controls 
(Fig. 3.17).
ISO (3xl0 10 - 3xl0*7 M) produced concentration- dependent inhibitions of 
NA-induced tone in aortic rings from SHR and WKY control rats. At low 
concentrations, ISO produced smaller inhibitions in aortic rings from SHR 
than in rings from WKY controls (Fig. 3.18). However, at higher concentrations 
there was no significant difference between ISO-induced relaxations in SHR and 
WKY rats (Fig. 3.18).
The Ca2+ -channel blocker, nifedipine (NIF, 10'9-3xl0‘6 M) caused concentration- 
dependent relaxation of aortic rings from both SHR and WKY rats (Fig. 3.19, 20). 
In rings precontracted with NA (5.6x1 O'9), NIF at low concentrations, produced 
smaller relaxations in rings from SHR than in rings from WKY but, at higher 
concentrations, there was a greater relaxation of rings from SHR than in those from 
WKY control (Fig. 3.19). At all concentrations exept the highest, NIF produced
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smaller relaxations of KC1 (1. 3x 102M)-induced tone in rings from SHR than in rings 
from SHR than in those from WKY (Fig. 3.20).
SECTION 2: BIOCHEMICAL RESPONSES TO VASOCONSTRICTORS AND 
VASORELAXANTS IN ISOLATED AORTIC RINGS FROM 
WISTAR RATS.
The aims of these experiments were first, to examine the effects of 
vasoconstrictors on phosphoinositide (PI) hydrolysis and secondly, to determine the 
effects of vasorelaxants on the levels of the inhibitory second messengers, 
cAMP and cGMP. A third objective was to determine the effects of 
vasorelaxants on NA-induced Pl-hydrolysis in the isolated vasculature.
PART 1: The effects of vasoconstrictors alone and in combination with
vasorelaxants on Pl-hydrolysis in aortic rings from Wistar rats.
The time-course of the effect of NA on Pl-hydrolysis in aortic rings from Wistar 
rats is shown in Fig. 3.29. NA (10-4 M) increased the formation of (^-inosito l 
phosphates, which continued to accumulate over the period of 1 hour, during 
which the experiment was carried out. NA (10‘10-10'5 M) caused a 
concentration-dependent accumulation of 3H-inositol phosphates [(3H)-IPs] in 
isolated aortic rings from Wistar rats (Fig. 3.30). This ability of NA (6.2xlCT6 M) 
to increase the formation of [fHJ-IPs] in aortic rings was reduced to control levels 
by the a r  adrenoceptor antagonist, prazosin (Id 6 M) (Fig. 3.31).
64
Surprisingly, KC1 (3x1 O'2 M) also increased the accumulation of [^Fty-IPs] in rat 
aortic rings (Fig. 3.32). This effect of KC1 was inhibited by NIF (KT5 M) (Fig. 
3.33).
The vasorelaxants, ACh (10‘5 M) and SNP (10-6 M) inhibited the NA-induced 
Pl-response in aortic rings from Wistar rats (Fig. 3.34, 3.36). Removal of the 
endothelium either mechanically, by rubbing, or chemically with Triton-X 100 
(0.1% V/V) abolished the inhibitory action of ACh on NA-induced Pl-hydrolysis 
(Fig. 3.35). The permeant cyclic GMP analogue, 8 -bromo-cGMP (3x1 O'4 M) also 
inhibited the NA-induced Pl-response (Fig. 3.37). The 11-adrenoceptor agonists, 
isoprenaline (ISO, Id 6 M) (Fig. 3.38) and salbutamol (SAL, 10-6 M) (Fig. 3.39) 
also inhibited the NA-induced Pl-response. This effect of the B-adrenoceptor 
agonists was antagonized by propranolol (PROP, 5x1 O'6 M).
The phosphodiesterase inhibitors, IBMX (10"6 M) (Fig. 3.40) and theophylline 
(5x10^ M) (Fig. 3.41) also inhibited the NA-induced Pl-response. The 
directly-acting activator of adenylate cyclase, forskolin (FOR, 10-6 M), inhibited the 
NA-induced Pl-response (Fig. 3.42). The combination of SNP (10~6 M) and FOR 
(10*6 M) produced a greater inhibition than was produced by either drug alone 
(Fig. 3.43). The permeant cAMP analogue, 8 -bromo-cAMP (3x1 O'4 M), also 
inhibited the NA-induced Pl-response (Fig. 3.44). NIF (10-6 M) inhibited the 
NA-induced Pl-response in aortic rings (Fig. 3.45).
It was notable that the vasorelaxants, ACh (10 /zM), SNP (1 /zM), FOR (1 /zM), 
IBMX (1 /zM), 8 -bromo-cGMP (0.3mM) and 8 -bromo-cAMP (0.3mM) all inhibited 
the NA-induced Pl-response by less than 50% although the relaxations they 
produced were greater than 50%.
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These results suggest that drugs which either increase the synthesis of cAMP 
or cGMP or prevent the breakdown of these cyclic nucleotides in vascular smooth 
muscle, can inhibit the NA-induced Pl-response, which underlies these 
contractions.
PART 2: The effect of vasorelaxants on cyclic nucleotide levels in aortic
rings from Wistar rats.
In the presence of NA (3xlO"8 M), ACh (10‘5 M) and SNP (10'6 M) increased the 
levels of cGMP in isolated aortic rings from Wistar rats. At a concentration which 
maximally relaxed vascular smooth muscle that had been precontracted with NA 
(3x1 O'8 M), ACh produced a 4-fold increase in cGMP levels (Fig. 3.53). In 
contrast, SNP (10*6 M) also abolished the NA-induced tone, produced a 35-fold 
increase in cGMP levels (Fig. 3.54).
ISO (10‘8 M) and FOR (10 6 M) increased the cAMP levels in aortic rings (in the 
presence of NA, 3x10‘8 M) to 2.5 times and 4 times control values (Fig. 3.55, 
3.56).
PART 3: The effects of vasoconstrictors on NA-induced Pl-hydrolysis in
aortic rings from SHR and WKY rats.
NA (10-8- i a 3 M) induced Pl-hydrolysis in aortic rings from SHR and WKY rats 
in a concentration-dependent manner (Fig. 3.46). The results obtained in these 
experiments were influenced by the age of the animals used. In experiments with rats
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that were between 10 and 12 weeks old, NA (lOMO*6 M) produced a larger 
Pl-response in aortic rings from SHR than in rings from WKY. In these rings, the 
higher concentrations of NA (lO'MO'3 M) produced a similar Pl-response in 
rings from SHR and WKY rats. In contrast, in experiments with older rats 
(18-20 weeks), NA (10*8-10‘3 M) produced a smaller Pl-response in rings from SHR 
than in rings from WKY rats (Fig. 3.47).
PART 4: The inhibitory effects of vasorelaxants that increase the synthesis
of cyclic nucleotides on the NA-induced PI- response and on cAMP 
and cGMP synthesis in aortic rings from SHR and WKY rats.
ACh (10‘5 M) and SNP (10'6 M) inhibited the NA-induced Pl-response in rings 
from both SHR and in WKY control rats (Fig. 3.48, 3.49) but the inhibitions 
produced by both ACh and SNP were larger in rings from SHR than in those from 
WKY (Fig. 3.48, 3.49). In contrast, ISO (108 M) and FOR (10-6 M) also 
inhibited the NA-induced Pl-response but the inhibitions produced by both drugs 
were smaller in rings from SHR than in those from WKY rats (Fig. 3.50, 3.51).
ACh (10'5 M) and SNP (10‘6 M) increased the levels of cGMP in isolated 
aortic rings from SHR and WKY rats but the increase was greater in rings from 
SHR than in those from WKY rats (Fig. 3.57, 3.58). ISO (10 8 M) and FOR (10"6 
M) increased the levels of cAMP in aortic rings from SHR and WKY but the 
increase in cAMP levels was smaller in rings from SHR than in those from WKY 
control rats (Fig. 3.59, 3.60).
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SECTION 3: MECHANICAL AND BIOCHEMICAL EXPERIMENTS IN RAT 
ISOLATED TAIL ARTERY.
The aims of these experiments were, first to examine mechanical responses, 
including tension recording and also perfusion pressure responses to vasoconstrictors 
and secondly, to investigate vasoconstrictor-induced Pl-responses in rat tail artery.
PART 1: Mechanical responses to vasoconstrictors in isolated tail artery
rings from SHR and WKY control rats.
NA (3xl0'9-10*5 M) produced concentration-dependent contractions in isolated tail 
artery rings from WKY and SHR rats. NA at low concentrations (3xl0'9-10'6 M) 
produced responses that were not significantly different in rings from SHR and 
WKY rats, but at higher concentrations (3x1 O'6 -10'5 M) tail artery rings from SHR 
were significantly more responsive to NA than those from WKY control rats (Fig. 
3.21).
These results can also be expressed as percentages of the maximum response. 
(Fig. 3.22). There was no significant difference in the responses of rings from SHR 
and WKY when expressed in this manner.
KC1 (10'2-l(ri M) produced concentration-dependent contractions in isolated tail 
artery rings from WKY and SHR rats. Except at one concentration, responses to KC1 
were not significantly different in rings from SHR and from WKY controls. (Fig. 
3.25)
When these results were expressed as percentages of the maximum response.
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(Fig. 3.26), there was no significant difference in the responses of rings from SHR 
and from WKY controls.
PART 2: Perfusion pressure responses to vasoconstrictors in perfused tail
artery segments from SHR and WKY control rats.
NA (3xl0'9-10'5 M) produced concentration-dependent contractions in isolated 
perfused tail artery segments from WKY and SHR rats. Lower concentrations of NA 
(3xl0'9-3xl0"6 M) produced responses that were not significantly different in 
segments from SHR and WKY rats. However at the highest concentration (lO-5 M), 
tail artery segments from SHR were significantly more responsive to NA compared 
to those from WKY control rats. (Fig. 3.23).
When these results were expressed as percentages of the maximum response 
(Fig. 3.24), except in highest and lowest concentrations, the responses were 
significantly smaller in segments from SHR than those of WKY controls.
KC1 (10‘2-5xl0'1 M) produced concentration-dependent contractions in isolated 
perfused tail artery segments from WKY and SHR rats. There was no significant 
difference between the responses to KC1 in rings from SHR and WKY control. (Fig. 
3.27).
PART 3: Experiments on Pl-hydrolysis in rat tail artery segments from
WKY and SHR.
NA (10'6 M, 10‘5 M) produced concentration-dependent Pl-hydrolysis in tail
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artery segments from SHR and WKY control rats. The basal (control) level of 
Pl-hydrolysis in segments from the SHR was significantly greater than segments 
from the WKY rats (Fig. 3.51).
NA (106 M and 10'5 M) significantly increased Pl-hydrolysis in tail artery 
segments from both SHR and WKY rats. There was no significant difference in 
response to NA (10-6 M) in segments from SHR and WKY, but a higher 
concentration of NA (10~5 M) induced significantly greater Pl-hydrolysis in segments 
from SHR than in WKY controls (Fig. 3.52).
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Fig.3.1.
Concentration-response curve for NA in aortic rings from Wistar rats. Tension was 
recorded. NA (1010 - 3xl0"7M) induced concentration-dependent contractions of aortic 
rings. At higher concentrations (10'7-3xl0'5M) responses to NA decreased with increasing 
concentration. Points are means ±  s.e.mean. (n=10).
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Fig.3.2.
Time-course for NA-induced contraction in aortic rings from Wistar rats. Tension was 
recorded. NA (lO^M) induced time-dependent contraction of aortic rings. Muscle tone 
stabilised after 5 mins. Points are means ±  s.e.mean. (n= 8 ).
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Fig. 3.3.
Concentration-response curve for KC1 in aortic rings from Wistar rats. Tension was recorded.
KC1 induced concentration-dependent contractions over a narrow concentration range. Points
are means + s.e.mean. (n=8).
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Fig. 3.4.
Comparison between the contractile effects of NA and KC1 in aortic rings from Wistar rats. 
Muscle tension was recorded. NA was more potent than KC1. Points are means ±  s.e.mean. 
(n= 8 )
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7ig. 3.5.
Uoncentration-response curve for ACh in aortic rings from Wistar rats. The degree of muscle
elaxation produced by ACh was recorded and expressed as a % of the contraction elicited by
^A (3xl0**M). Points are means ± s.e.mean. (n=8).
C/R curve for SNP in Wistar rat aorta
1 0 0 -i
8 0 -
c
o
•+-<
09
X
<0
0)
CC
6 0 -
4 0 -
2 0 -
-  1 1 - 1 0  - 9
Log conc. [M]
i
- 7
Fig. 3.6.
Concentration-response curve for SNP in aortic rings from Wistar rats. The degree of muscle
relaxation produced by SNP was recorded and expressed as, a % of the contraction elicited by
NA (SxlO^M). Points are means ± s.e.mean. (n=8).
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Fig. 3.7.
Comparison between the relaxant effects of ACh and SNP in aortic rings from Wistar rats. 
The degree of muscle relaxation produced by ACh and SNP was recorded and expressed as a 
% of the contraction elicited by NA (3xl0‘8M). Points are means +  s.e.mean. (n—8 ).
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Fig. 3.8.
Concentration-response curve for isoprenaline in aortic rings from Wistar rats. The muscle
relaxation produced by isoprenaline was recorded and expressed as a % of the contraction
elicited by NA (3xlO^M). Points are means ± s.e.mean. ( n = 8 ) .
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Honcentration-response curve for forskolin . in rat aortic rings from Wistar rats. The muscle
'elaxation produced by forskolin was recorded and expressed as a % of the contraction
dicited by NA (3xl0-8M). Points are means +  s.e.mean. (n^=8).
C/R curve for IBMX in Wistar rat aorta
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Fig. 3.10.
Concerttration-response curve for isobutylmethylxanthine (IBMX) in ?.ortic rings from Wistar 
rats. The muscle relaxation produced by IBMX was recorded and expressed as a % of the 
contraction elicited by NA (BxlO^M). Points are means ±  's.e.mean. (n= 8 ).
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Fig. 3.11.
M easurement o f blood pressure in conscious SHR and WKY rats. The blood pressure measured 
in SHR was significantly higher than that in WKY controls. (*** p <  0.001). Results are 
means ± s.e.m ean. (n =  12).
Measurement of weight in aortic rings
from WKY & SHR
0  WKY  
E2 S H R
Fig. 3.12.
M easurement o f weight o f aortic rings from SHR and WKY rats. A ortic rings from SHR were 
significantly heavier than those from WKY control rats. (*** p < 0 .  001). Results are means 
±  s.e.m ean. (n = 2 0 ).
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Fig. 3.13.
M easurement o f weight o f tail artery rings from SHR and WKY rats. Rings from SHR were 
significantly heavier than those from WKY control rats. (** p < 0 .  01). Results are means 
± s.e.m ean. (n= 32).
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C/R curve for NA in WKY & SHR aorta
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Fig. 3.14.
Concentration-response curves for NA in aortic rings from SHR and WKY control rats. 
Muscle tension was recorded. NA induced significantly smaller contractions in rings from 
SHR than in rings from WKY control rats. (* p<0.05, ** pCO.Ol, *** p<0.001). Points are 
means ±  s.e.mean. (n = 1 0 ).
C/R curve for KC1 in WKY & SHR aorta
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Fig. 3.15.
Concentration-response curves for KC1 in aortic rings from SHR and WKY control rats. 
Muscle tension was recorded. KC1 induced significantly smaller contractions in tissues 
from SHR than in tissues from WKY control rats. (* p<0.05, ** p<0.01, *** p < 0.001). 
Points are means ±  s.e.mean. (n=10).
C/R curve for ACh in WKY & SHR aorta
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Fig. 3.16.
Concentration-response curves for ACh in aortic rings from SHR and WKY control rats. 
Muscle relaxation was recorded and expressed as a % of contraction elicited by NA (5.6xlO*M). 
ACh-induced relaxation was not significantly different in rings from SHR and WKY controls. 
Points are means ±  s.e. means. (n= 8 ).
C/R curve for SNP in WKY & SHR aorta
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Fig. 3.17.
Concentration-response curves for SNP in aortic rings from SHR and WKY control rats. 
Muscle relaxation was recorded and expressed as a % of contraction elicited by NA (5.6x10" 
9M). SNP at low concentrations induced significantly smaller relaxations in rings from 
SHR than in rings from WKY controls. In contrast, at higher concentrations SNP induced 
significantly greater relaxations in rings from SHR than ig WKY controls. (* p<0.05, ** 
p<0.01, *** p<0.001). Points are means ±  s.e.mean. (n = 8 ).
C/R curve for isoprenaline in WKY & SHR aorta
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Fig. 3.18.
Concentration-response curves for isoprenaline in aortic rings from SHR and WKY control 
rats. Muscle relaxation was recorded and expressed as a % of the contraction elicited by NA 
(5.6x10^ M). Isoprenaline at low concentrations induced significantly smaller relaxations in 
rings from SHR than in WKY controls, .btft at higher concentrations there was no significant 
difference between the relaxation of rings from SHR and WKY controls. (* p<0.05, ** 
p<0.01, *** p <0.001). Points are means ±  s.e.mean. (n—8 ).
C/R curve for Nifedipine on NA-induced 
contraction in WKY & SHR aorta
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Fig. 3.19.
Concentration-response curves for nifedipine in aortic rings from SHR and WKY control rats. 
Muscle relaxation was recorded and expressed as a % of the contraction elicited by NA 
(5.6xl0*9 M). Nifedipine at low concentrations induced significantly weaker relaxations in 
rings from SHR than in those from WKY controls. In contrast, at higher concentrations 
nifedipine induced significantly greater relaxation in rings from SHR than in those from 
WKY rats (* p<0.05, ** p<0.01, *** pCO.OOl). Points are means +  s.e.mean. (n= 8 ).
C/R curve for nifedipine on KCl-induced 
contraction in WKY & SHR aorta
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Fig.3.20.
Concentration-response curve for nifedipine in aortic rings from SHR and WKY control rats. 
Muscle relaxation was recorded and expressed as a % of the contraction elicited by KC1 
(1.3xl0*2 M). nifedipine at all concentrations except the highest concentration induced 
significantly smaller relaxations in rings from SHR than in those from WKY controls. (* 
p<0.05, ** p<0.01, *** p<0.001). Points are means ±  s.e.mean. (n= 8 ).
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Fig. 3.21.
Concentration-response curves for NA in tail artery rings from SHR and WKY control rats. 
Muscle tension was recorded. Low concentrations of NA caused contractions that were not 
significantly different in rings from SHR and WKY controls. Higher concentrations of NA 
induced significantly greater contractions in rings from SHR than in those from WKY controls. 
(* p<0.05). Points shown are means ±  s.e.mean. (n=12)f.
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Fig. 3.22.
Concentration-response curves for NA in tail artery rings from SHR and WKY control rats. 
Muscle tension was recorded. Results are expressed as percentages of the maximum 
response. There was no significant difference between the NA-induced responses obtained in 
rings from SHR and from WKY controls. Points are means ±  s.e.mean. (n=12).
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Fig. 3.23.
Concentration-response curves for NA in perfused tail artery segments from SHR and 
WKY control rats. Perfusion pressure was recorded and expressed in mm Hg. NA at low 
concentrations produced similar responses in arteries from SHR and WKY controls, but at 
higher concentrations NA produced significantly greater responses in segments from SHR than 
in those from WKY controls. (** p<0.01). Points are means ±  s.e.mean. (n= 8 ).
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Fig. 3.24.
Concentration-response curves for NA in perfused tail artery segments from SHR and 
WKY control rats. Perfusion pressure was recorded and expressed as percentages of the 
naximum response. NA at all concentrations except the highest, produced significantly 
•mailer responses in segments from SHR than in those WKY Controls. (** p<0.01). Points are 
neans ±  s.e.mean. (n= 8 ).
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Fig. 3.25.
Concentration-response curves for KC1 in tail artery rings from SHR and WKY control rats. 
Muscle tension was recorded. Apart from the responses obtained at one concentration, 
responses to KC1, were not significantly different in rings from SHR and WKY controls. (** 
p<0.05). Points are means ±  s.e.mean. (n = 12).
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Fig. 3.26.
Concentration-response curves for KCI in tail artery rings from SHR and WKY control rats. 
Muscle tension was recorded. Results were expressed as percentages of the maximum 
response. Responses to NA were not significantly different in rings from SHR and 
WKY controls. Points are means ±  s.e.mean. (n=12).
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Fig. 3.27.
Concentration-response curves for KCI in perfused tail artery segments from SHR and 
WKY control rats. Perfusion pressure was recorded and responses to KCI were expressed 
in mm Hg. Responses to NA were not different in rings from SHR and WKY controls. Points 
are means ±  s.e.mean. (n= 8 ).
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Fig. 3.28.
Concentration-response curves for KCI in perfused tail artery segments from SHR and 
WKY control rats. Perfusion pressure was recorded and responses were expressed as 
percentages of the maximum response. KCl-induced responses were not significantly different 
in arteries from SHR than in WKY controls. Points shown are means ±  s.e.mean. (n = 8 ).
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Fig.3.29.
Time-course of NA-induced Pl-hydrolysis in aortic rings from Wistar rats. Pl-hydrolysis was 
monitored and expressed as disintegrations per minute (d.p.m.) mg weight of tissue. The 
time-course of the effect of NA (104 M) is shown. Points are means ±  s.e.mean. (n= 8 ).
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Fig. 3.30.
Concentration-response curve for NA-induced Pl-hydrolysis in aortic rings from Wistar rats. 
Pl-hydrolysis was monitored by measuring the levels of (^-inosito l phosphates and expressed 
as percentages of the control (basal) Pl-response. Points are means +  s.e.mean. (n= 8 ).
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Fig. 3.31.
Effect of prazosin on NA-induced Pl-hydrolysis in aortic rings from Wistar rats. Pl-hydrolysis 
was monitored by measuring the levels of (^-inosito l phosphates. NA (b^xlO^M) 
significantly increased Pl-hydrolysis above the control (CTL) level. (*** p < 0.001). 
Prazosin (PRAZ, lxlO^M) significantly inhibited the NA-induced Pl-hydrolysis to the control 
level.(+ +  + p < 0.001). Results are means ±  s.e.mean. (n = 8 ).
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Fig. 3.32.
Effect of KCI on Pl-hydrolysis in aortic rings from Wistar rats. Pl-hydrolysis was monitored 
by mieasuring the level of (^-inosito l phosphates. KCI (30mM) significantly increased the 
Pl-hydrolysis above the control level. (* p<0.05). Results;are means ±  s.e.mean. (n=12).
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Fig. 3.33.
Effect of nifedipine on KCl-induced Pl-hydrolysis in aortic rings from Wistar rats. The 
Pl-hydrolysis was monitored by measuring the level of ^HJ-inositol phosphates. KCI (30mM) 
significantly increased Pl-hydrolysis above control levels. (* p<0.05). In the presence of 
nifedipine (NIF, lO^M), the effect of KCI was significantly inhibited. ( + p < 0.05). Results 
are means ±  s.e.m. (n =  1 0 ).
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Fig. 3.34.
Inhibitory effect of ACh on NA-induced Pl-hydrolysis in aortic rings from Wistar rats. 
Pl-hydrolysis was monitored by measuring the level of ^HQ-inositol phosphates. NA (6.2x10' 
6M) significantly increased Pl-hydrolysis'above the control level. (*** p <0.001). ACh 
significantly inhibited the NA-induced Pl-hydrolysis. (+ +  p<0.01). The endothelium was 
intact in these experiments. Results are means +  s.e.m. (n= 8 ).
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Fig. 3.35.
Inhibitory effect of ACh on NA-induced Pl-hydrolysis in the presence and absence of 
endothelium in aortic rings from Wistar rats. Pl-hydrolysis was monitored by measuring 
the level of (3H)-inositol phosphates. NA (6.2xlO^M) significantly increased Pl-hydrolysis 
above control levels. (*** p < 0.001). ACh (I0*5M) significantly inhibited NA-induced 
Pl-hydrolysis. ( + +  p<  0.01). When the endothelium was removed either mechanically (MER) 
by rubbing or chemically (CER) with Triton X-100 (0.1%; V/V), the inhibitory effect of 
ACh (10'5M) was completely abolished. (NS). Results are means ±  s.e.mean. (n= 8 ).
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Fig. 3.36.
Inhibitory effect of SNP on NA-induced Pl-hydrolysis in aortic rings from Wistar rats. 
Pl-hydrolysis was monitored by measuring fFQ-inositol phosphates. NA (b^xlO^M) 
significantly increased Pl-hydrolysis above the control levels. (*** p <0.001). SNP (10^M) 
significantly inhibited NA-indued Pl-hydrolysis (+  + +  p <0.001). Results are means ±  
s.e.mean. (n = 1 0 )
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Fig. 3.37.
Inhibitory effect of 8 -Bromo-cGMP on NA-induced Pl-hydrolysis in aortic rings from Wistar 
rats. Pl-hydrolysis was monitored by measuring (^-inosito l phosphates. NA (6 .2x10^) 
significantly increased Pl-hydrolysis above control levels. (*** p < 0  001). 8 -Bromo-cGMP 
(0.3mM) significantly inhibited the NA-induced Pl-hydrolysis (+  +  +  p <0.001). Results 
are means ±  s.e.mean. (n= 8 ). t "
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Fig. 3.38.
Inhibitory effect of isoprenaline on NA-induced Pl-hydrolysis in aortic rings from Wistar 
rats. Pl-hydrolysis was monitored by measuring ^HJ-inositol phosphates. NA (6.2xlO^M) 
significantly increased Pl-hydrolysis above control, levels. (*** P <  0.001) Isoprenaline 
(ISO, 10~8M) significantly inhibited the NA-induced Pl-hydrolysis ( + +  p<0.01). This 
inhibitory effect was abolished by propranolol (5xl0^M). (NS). Results are means ±  s.e.mean. 
(n= 8 ). i"
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Fig. 3.39.
Inhibitory effect of salbutamol on NA-induced Pl-hydrolysis in aortic rings from Wistar 
rats. Pl-hydrolysis was monitored by measuring (^-inositol phosphates. NA (6.2xlO'6M) 
significantly increased Pl-hydrolysis above control levels. (*** p <  0.001). Salbutamol 
(SAL, lO^M) significantly inhibited the NA-induced Pl-hydrolysis. (+  p<0.05). This 
inhibitory effect of SAL was completely abolished by propranolol (PROP, 5xl0^M). Results 
are means ±  s.e.mean. (n= 8 ).
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Fig. 3.40.
Inhibitory effect of isobutylmethylxanthine (IBMX) on NA-induced Pl-hydrolysis in aortic 
rings from Wistar rats. Pl-hydrolysis was monitored by measuring (^-inosito l phosphates. 
NA (6.2xlO^M) significantly increased Pl-hydrolysis above control levels (*** p <  0 .0 0 1 ). 
IBMX (I0^M) significantly inhibited the NA-induced Pl-hydrolysis (+ +  p <0.01). Results 
are means ±  s.e.mean. (n = 8 ).
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Fig. 3.41.
Inhibitory effect of theophylline on NA-induced Pl-hydrolysis in aortic rings from Wistar 
rats. Pl-hydrolysis was monitored by measuring (^HJ-inositol phosphates. NA (b^xlO^M) 
significantly increased Pl-hydrolysis above control levels. (*** p <  0.001). Theophylline 
(SxlO^M) significantly inhibited the NA-induced Pl-jhydrolysis ( + +  p<0.01, *** 
p <0.001). Results are means ±  s.e.mean. (n= 8 ).
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Fig. 3.42.
Inhibitory effect of forskolin on NA-induced Pl-hydrolysis in aortic rings from Wistar 
rats. Pl-hydrolysis was monitored by measuring (^-inosito l phosphates. NA (6.2xl0*M) 
significantly increased Pl-hydrolysis above control levels. (*** p <  0.001). Forskolin
(FOR, lO^M) significantly inhibited the NA-induced Pl-hydrolysis (+ 4 -4 -p <0.001). Results 
are means +  s.e.mean. (n= 8 ).
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Fig. 3.43.
The separate and combined inhibitory effects of SNP (S) and forskolin (F) on NA-induced 
Pl-hydrolysis in aortic rings from Wistar rats. Pl-hydrolysis was monitored by measuring 
(3H)-inositol phosphates. NA (6.2xlO^M). significantly increased Pl-hydrolysis above control 
levels. (*** p <0.001). SNP (S, lO^M) and forskolin (F, 10^M) individually inhibited the 
NA-induced Pl-hydrolysis. Combination of these drugs produced a significantly larger inhibition 
of NA-induced Pl-hydrolysis. (+  + +  p<0.001). Results are means ±  s.e.mean. (n = 8 ).
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Fig. 3.44.
Inhibitory effect of 8 -Bromo-cAMP on NA-induced Pl-hydrolysis in aortic rings from Wistar 
rats. Pl-hydrolysis was monitored by measuring (3H)-inositol phosphates. NA (6.2xlO^M) 
significantly increased Pl-hydrolysis above control levels. (*** p <0.001). 8 -Bromo-cAMP 
(0.3mM) significantly inhibited the NA-induced Pl-hydrolysis (+  +  + p <0.001). Results 
are means ±  s.e.mean. (n= 8 ). ;
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Fig. 3.45.
Inhibitory effect of nifedipine (NIF) on NA-induced Pl-hydrolysis in aortic rings from Wistar 
rats. Pl-hydrolysis was monitored by measuring (3H)-inositol phosphates. NA (6.2xlO^M) 
significantly increased Pl-hydrolysis above control levels. (*** p < 0.001). NIF (lO^M)
significantly inhibited the NA-induced Pl-hydrolysis (+ +  p<0.01). Results are means ±  
s.e.mean. (n= 8 )
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Fig. 3.46.
Concentration-response curves for NA-induced Pl-hydrolysis in aortic rings from SHR and 
WKY control rats (10-12 weeks old). Pl-hydrolysis was monitored by measuring the level 
of (^-inosito l phosphates. Low concentrations of NA induced significantly higher levels of 
Pl-hydrolysis in rings from SHR than- in those from WKY controls, but at higher 
concentrations there was no significant difference between responses obtained in rings from 
SHR and WKY. (*p<0.05, **p<0.01, * **p< 0.001). Points are means ±  s.e.mean. (n= 8 ).
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Fig. 3.47.
Concentration-response curves for NA-induced Pl-hydrolysis in aortic rings from SHR and 
WKY control rats (18-20 weeks old). Pl-hydrolysis was monitored by measuring the 
levels of (^-inosito l phosphates. NA at all concentrations induced significantly less 
Pl-hydrolysis in rings from SHR than in those from WKY controls. (* p<0.05, ** p<0.01, 
***p<0.001). Points are means ±  s.e.mean. (n= 8 ).
Inhibitory effect of ACh on Pl-hydrolysis
in WKY & SHR aorta
500 □  WKY 03 SHR
400 -
XX
<D3
CO
~  300
O)
E
E
Q .
■d 20 0  ~
1 00  -
CTL NA NA+ACh
Fig 3.48.
Inhibitory effect of ACh on NA-induced Pl-hydrolysis in aortic rings from SHR and WKY 
control rats. Pl-hydrolysis was monitored by measuring the levels of (3H)-inositol phosphates. 
NA (6.2xlO^M) significantly increased Pl-hydrolysis above the control level. (*** p < 0.001). 
ACh (10‘5M) significantly inhibited this NA-induced Pl-hydrolysis in both SHR and WKY 
controls, (xx p<0.01). The inhibitory effect of ACh was significantly greater in rings from 
SHR than in rings from WKY rats (+  p<0.05). Results are means ±  s.e.mean. (n= 8 ).
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Fig 3.49.
Inhibitory effect of SNP on NA-induced Pl-hydrolysis in aortic rings from SHR and WKY 
control rats. Pl-hydrolysis was monitored by measuring the levels of (^-inosito l phosphates. 
NA (6.2xlO^M) significantly increased Pl-hydrolysis above the control levels. (*** 
p < 0.001). SNP (lO^M) significantly inhibited NA-induced Pl-hydrolysis in rings from SHR 
and in those from WKY controls, (xx p<0.01). The inhibitory effect of SNP was 
significantly greater in rings from SHR than in WKY rings (+ +  p<0.01). Results are 
means ±  s.e.mean. (n= 8 ).
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Fig 3.50.
Inhibitory effect of isoprenaline (ISO) on NA-induced Pl-hydrolysis in aortic rings from SHR 
and WKY control rats. Pl-hydrolysis was monitored by measuring the levels of (^-inositol 
phosphates. NA (b^xlO^M) significantly increased Pl-hydrolysis above the control levels. (*** 
p <0.001). ISO (10-8 M) significantly inhibited NA-induced Pl-hydrolysis in rings from SHR 
and in those from WKY controls, (xx p<0.01). The inhibitory effect of ISO was significantly 
smaller in rings from SHR than in those from WKY controls.. (+  p<0.05). Results are means 
±  s.e.mean. (n= 8 ).
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Fig 3.51.
Inhibitory effect o f forskolin (FOR, lO^M) on NA-induced PI- hydrolysis in aortic rings from 
SHR and WKY control rats. PI- hydrolysis was monitored by measuring the levels of 
(3H)-inositol phosphates. NA ( 6 .2 x 1 0 ^ )  significantly increased Pl-hydrolysis above the 
control levels. (*** p < 0.001). FOR (lO^M) significantly inhibited NA-induced Pl-hydrolysis 
in rings from SHR and those from WKY controls, (xx p < 0 .0 1 ) . The inhibitory effect o f ISO 
was significantly smaller in rings from SHR than in those from WKY controls. ( + +  p < 0 .0 5 ) . 
Results are means ± s.e.m ean. (n =  8).
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Fig. 3.52.
Effect of NA on Pl-hydrolysis in tail artery rings from SHR and WKY control rats. 
Pl-hydrolysis was monitored by measuring the level of (^-inositol phosphates. NA increased 
Pl-hydrolysis in rings from both SHR and WKY rats. (** p<0.01, *** p<0.001). The 
responses to NA (lxlO^M) was not significantly different in rings from SHR and in those 
from WKY controls. The response to NA (1x10'5M) was significantly greater in rings from 
SHR than in those from WKY controls. (+ +  p<0.01). Results are means ±  s.e.mean. (n= 8 ).
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Fig. 3.53.
Effect of ACh on cGMP levels in aortic rings from Wistar rats. In rings pretreated with NA
(3xl0~® M), ACh (10*5M) significantly increased cGMP levels above the control (basal)
level (*** p < 0.001). Results are means ±  s.e.mean. (n^=8).
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Fig. 3.54.
Effect of SNP on cGMP levels in aortic rings from Wistar rats. In aortic rings pretreated 
with NA (3x10'8M), SNP (lO^M) significantly increased cGMP levels above the control (basal) 
level (***p<0.001). Results are means ±  s.e.mean. (n= 8 ).
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Fig. 3.55.
Effect of isoprenaline (ISO) on cAMP levels in aortic rings from Wistar rats. In rings 
pretreated with NA (3xl0'8M), ISO (10‘8M) significantly increased cAMP levels above the 
control (basal) level. (*** p<0.001). Results are means s.e.mean. (n= 8 ).
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Fig. 3.56.
Effect of forskolin (FOR) on cAMP levels in aortic rings from Wistar rat aorta. In rings 
pretreated with NA (3xl0'8M), FOR (lO^M) significantly increased cAMP levels above 
the control level (basal). (*** p<0.001). Results are means ±  s.e.mean. (n = 8 ).
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Fig. 3.57.
Effect o f ACh on cGM P levels in aortic rings from SHR and WKY control rats. In rings 
pretreated with NA (5.6xlCI9M), ACh (10'5M) significantly increased cGM P levels above the 
control (basal) level. (*** p < 0 .0 0 1 ). This effect was significantly greater in rings from SHR 
than in those from WKY controls. ( + +  p < 0 .0 1 ) . Results are means +  s.e.m ean. (n = 8 ).
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Fig. 3.58.
Effect o f SNP on cGM P levels in aortic rings from SHR and WKY control rats. In rings 
pretreated with NA (5 .6X10'9M), SNP (lO^M) significantly increased cGM P levels above the 
control (basal) levels. (*** p < 0.001). The responses to SNP was significantly higher in rings 
from SHR than in those from WKY controls. ( +  +  T p < 0 .0 0 1 ) . Results are means +  
s.e.m ean. (n =  8).
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Fig. 3.59.
Effect o f isoprenaline (ISO) on cAM P levels in aortic rings from SHR and WKY control rats. 
In rings pretreated with NA (5.6xlCf9M ), ISOP (lO^M) significantly increased cAM P levels 
above the control (basal) level. (*** p < 0.001). This effect o f ISO was significantly smaller 
in rings from SHR than in those from WKY controls. ( + +  p < 0 .0 1 ) . Result are means ± 
s.e.m ean. (n = 8 ).
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Fig. 3.60.
Effect o f forskolin (FOR) on cAMP levels in aortic rings from SHR and WKY control rats. 
In rings pretreated with NA (5.6xlCf9M), FOR (lO^M) significantly increased cAM P levels. 
(*** p <  0.001). This effect of FOR was significantly smaller in rings from SHR than in those 
from WKY controls. (+  +  p < 0 .0 1 ) . Results are means ±  s.e.m ean. (n =  8).
CHAPTER FOUR
DISCUSSION
DISCUSSION:
In the cardiovascular system, the total peripheral resistance (TPR) to the flow 
of blood is dependent on the level of vascular tone, which is the resultant of 
vascular smooth muscle contraction and relaxation. The elevated arterial pressure 
that occurs in hypertension is the result of increased TPR, probably caused by 
changes in the structure and functioning of the blood vessels (Webb & Bohr, 1987). 
Since vascular smooth muscle tone has an essential role in regulating TPR and in 
turn, in regulating blood pressure, this study examined the mechanisms that 
modulate tone in normal vasculature and in vasculature from hypertensive 
rats and considered the possibility that in hypertension, changes may occur in the 
capacity of the vascular smooth muscle to contract or relax. The mechanical 
responses of isolated arteries were examined together with the corresponding 
biochemical responses asssociated with contraction and relaxation. In particular, 
the effects of vasoconstrictors and vasorelaxants on the coupling mechanisms and 
second messengers that regulate vascular tone were investigated.
In this study, rat isolated aortic rings and tail artery rings were compared, since 
these vessels were representative respectively of conducting and resistance vessels 
and also since they allowed mechanical and biochemical responses to be readily 
investigated.
This study was divided into three sections, which were:
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1. Preliminary mechanical and biochemical experiments to examine vascular 
contraction and relaxation in the isolated aorta from control Wistar rats.
2. Investigation of the mechanical and biochemical responses that occur in aortic 
rings from SHR and WKY control rats in response to vasoconstrictors and 
vasorelaxants.
3. Investigation of the mechanical and biochemical responses that occur in isolated 
tail artery rings from SHR and WKY control rats.
SECTION 1: Study of pharmacological and biochemical mechanisms 
modulating tone in Wistar rat aorta.
Throughout this study the responses of rat aortic rings were recorded 
isometrically (Fig. 2.1) and standard methods commonly cited in the literature 
were employed to prepare the aortic rings and record their responses (Cauvin & 
Malik, 1984; Rapoport, 1987). True isometric recording occurs in tissues that 
contract without any shortening of the muscle fibres. This is achieved when the 
applied tension, which is the "opposing force", exceeds the tension developed by the 
tissue, without overstretching the muscle fibre. A tension of 2g was applied to aortic 
rings and this exceeded the tension developed by the tissue. In all experiments 
in which contractile responses to vasoconsrictors were examined, the tissues were 
weighed so that the results could be expressed as g.mg' 1 tissue. This was 
necessary since blood vessels from hypertensive rats were generally heavier and 
thicker-walled than those from controls, presumably because the smooth muscle had 
undergone hypertrophy and hyperplasia.
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Since each aortic ring was suspended in the organ bath between hooks, 
inserted into the lumen, another factor that had to be considered was the 
condition of the endothelium. Clearly, there was a possibility that the wire hooks 
used to suspend the rings would damage the endothelium. Some damage may have 
occurred but it was insufficient to prevent endothelium-dependent vasorelaxants 
inhibiting tone. Moreover, throughout this study, a standard procedure was used and 
so if there was any damage, it would be likely to have been similar in all 
experiments. It has been reported that only a small fraction of the endothelial layer 
needs to be intact for complete relaxation of aortic rings (Peach et.al., 1985). It 
appears that normally only minor damage to the endothelium occurred and did not 
significantly influence the results obtained.
When it was necessary to remove the endothelium, this was achieved either 
mechanically by rubbing with forceps or chemically with Triton X-100 (0.1% 
V/V). These methods proved to be reliable and this was confirmed by light 
microscopy and by the absence of ACh-induced relaxations. During the rubbing of 
aortic rings, care was taken to avoid damaging the smooth muscle, whose capacity 
to contract and relax and ability to generate second messengers could have been 
impaired. There was no evidence that any such damage occurred.
Tissues were equilibrated for 60 minutes prior to the start of the experiments. 
This is a common procedure in such experiments, although the reason for it is not 
clear. A possible justification for this preincubation is that it was necessary to allow 
the re-establishment of the ionic gradients and the recovery of the coupling 
mechanisms. In the absence of such an equilibration period, responses to 
vasoconstrictors were variable.
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The method used to investigate agonist-induced PI- hydrolysis in this study 
measured myo-[3H]-inositol incorporation into membrane phosphoinositides and 
in turn, into the water soluble metabolites of Pl-hydrolysis (Fig. 1.2) This method 
has been widely used before by, among others, Fox and Friedman (1987), 
Hashimoto et al, (1986) and Chiu et al., (1987). This method was reliable and 
more specific than earlier techniques that measured 32P incorporation into 
phosphatidic acid as an index of Pl-hydrolysis.
In this study, lithium chloride was used to inhibit the phosphatase enzyme that 
hydrolyses the inositol phosphates (IPs) to release inositol (Fig. 2.4). Since IPs are 
generated during activation of, for example, aj-adrenoceptors, lithium chloride, by 
inhibiting the phosphatase enzyme, amplifies the observed PI response to 
vasoconstrictors such as NA. This effect of lithium chloride was confirmed (Fig. 
2.3).
In the preliminary experiments, mechanical and biochemical responses to 
vasoconstrictors and vasorelaxants that act by different mechanisms were 
examined. The results obtained in these experiments with NA, which causes 
Pl-hydrolysis and KC1, which depolarizes the cell membrane, largely confirmed 
previous findings. The results obtained with the endothelium- dependent 
vasorelaxant, acetylcholine (ACh) and the endothelium-independent vasorelaxant, 
sodium nitroprusside (SNP) and with the 8 -adrenoceptor agonist, isoprenaline 
(ISO), with the adenylate cyclase activator, forskolin (FOR) and also with the 
phosphodiesterase inhibitor isobutylmethylxanthine (IBMX) also confirmed previous 
findings. The justification of these experiments, which repeated the work and 
confirmed the results of others, was that it was necessary to demonstrate the
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suitability of the methods before looking for changes in the responsiveness or 
coupling mechanisms in blood vessel from hypertensive rats.
In this study, NA caused concentration-dependent contractions of rat isolated 
aortic rings (Fig. 3.1) and increased Pl-hydrolysis. These effects of NA were 
probably mediated via -adrenoceptors, since both the mechanical and biochemical 
responses to NA were inhibited by prazosin (Fig. 3.31). These results agree with 
previous observations (Villalobos-molina et al., 1982; Cauvin & Malik, 1984; 
Beckering et al., 1984a; Chiu et al., 1987).
There is a possibility that the contractile response to NA may have been 
mediated in part via post-junctional a 2-adrenoceptors, which do not cause 
Pl-hydrolysis (Ruffolo et al., 1982, 1987; Ruegg, 1988). However, more recent 
work suggests that the postjunctional a-adrenoceptors in the rat aorta should 
be classified as a homogenous population of c^-adreoceptors (Beckering et al., 
1984b, Chiu et al., 1986). In order to minimize any contribution from a- 
adrenoceptors other than aj-adrenoceptors, a more selective -adrenoceptor agonist, 
such as phenylephrine could have been used. Instead, NA was used in this study 
since it is the endogenous -adrenoceptor agonist, which also has the capacity to
hypertension. By using NA any such changes could be identified but might have 
been overlooked if a more specific aj-adrenoceptor agonist had been used.
An interesting feature of the concentration-response curve for NA was the 
decline in the response that occurred at higher concentrations (Fig. 3.1). This 
did not occur when the endothelium was removed and so may have been due
activate a2- and 15-adrenoceptors, whose may be modified in
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to the release of a vasodilator from the endothelium. A similar result was obtained 
by Cocks and Angus (1983), who attributed this phenomenon to the release of 
EDRF (NO), as a result of activation of endothelial a2-adrenoceptors. Similar 
results have been obtained by Miller and Vanhoutte in canine pulmonary and 
systemic vessels (1985). It is possible that the release of an endothelial 
vasorelaxant may also modify responses to lower concentrations of NA too. 
This possibility was confirmed by Carrier and White (1985) who showed that 
removing the endothelium in rat aorta enhanced both a r  and a2- 
adrenoceptor-mediated responses. Another possibility is that at high concentrations, 
fl2-adrenoceptors are also activated, so that the a j-adrenoceptor-mediated 
contraction is attenuated. One possibility that can probably be excluded is that the 
NA was oxidised. This was avoided since the bathing medium contained, the 
anti-oxidant, ascorbic acid (0.23 mM) and EDTA (0.06 mM) (Gillespie & Sheng, 
1988).
The results obtained with KC1 were interesting (Fig. 3.3), since KC1 was not only 
less potent than NA but produced a smaller maximum contraction. Although both 
agonists increase intracellular free calcium [Ca2+]; levels, albeit by different 
mechanisms, the difference in the maximum responses suggests that there are likely 
to be differences in the ability of vasorelaxants to inhibit NA and KCl-induced tone. 
In this study KC1 (3x10^ M), which depolarizes the cell and causes vascular smooth 
muscle to contract by the influx of Ca2+, increased the accumulation of [3H]-IPs. 
This result is consistent with previous observations, which indicated that 
KCl-induced depolarization increased the accumulation of IPs (Novotny et al.,
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1983; Bone et al., 1984; Berridge, 1987; Sasaguri & Watson 1988; ; Delahunty et 
al., 1988; Lai et al., 1989; Watson et al., 1990). This result is however, 
contradicted by the work of Chiu et al., (1986) in vascular smooth muscle, 
Rebecchi and Gershengom (1983) in GH3 pituitary tumour cells, and by Akhtar and 
Abdel- Latif (1984) in iris smooth muscle.
There are a number of possible explanations of this discrepancy. First, high 
concentrations of K+ can depolarize nerves and release NA. It has also been 
reported that the Ca2+ -ionophore A23187, can cause release of NA from 
adrenergic nerve terminals in smooth muscle (Cohen et al., 1981). Moreover, in 
the iris smooth muscle, the ionophore, A23187 has also been shown to cause 
accumulation of IP3, an effect which is secondary to the release of 
neurotransmitters by the ionophore, since this effect of A23187 was inhibited by 
prazosin (Akhtar & Abdel-Latif, 1984). However, since the rat thoracic aorta has 
a sparce adrenergic innervation (Kuchii et al., 1973), KCl-induced release of NA 
would not contribute to or only have a minor effect in causing accumulation of IPs. 
The inability of the indirect sympathomimetic, tyramine to contract the aorta 
supports the view that neuronal NA plays little part in the response to KC1 in this 
tissue.
The second, more likely possibility is that Ca2+ influx caused activation of PLC 
and in turn caused accumulation of IPs. It has been suggested by Litosch, (1990) 
that the elevation of [Ca2+]i may increase net production of IPs, either through 
activation of cytosolic or membrane PLC or both. In this study, KCl-induced 
activation of Pl-hydrolysis was abolished in the presence of the voltage-dependent 
Ca2+- channel blocker, nifedipine (10‘6 M). In conclusion, these results suggest that
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Ca2+-influx may play a part in promoting Pl-hydrolysis, since when Ca2+-influx, 
was blocked, this effect no longer occurred.
Since the detailed mechanism of vascular relaxation is still unclear, the effect 
of different vasorelaxant agents were examined in aortic rings from Wistar rats.
In this study the endothelium-dependent vasorelaxants, ACh (3xlO'9-3xlO'6 M) 
(Fig. 3.5), and the endothelium- independent vasorelaxant, SNP (10'1°-3xl0'6 M) 
(Fig. 3.6), relaxed isolated aortic rings that had been precontracted with NA (EC75, 
3x1 O'8 M), in a concentration-dependent manner. The maximal inhibition of 
NA-induced tone produced by ACh (1 nM), was 80% but that produced by SNP (30 
nM) was 100% (Fig. 3.7). It is possible that the ability of ACh to produce only 
80% inhibition is due to the fact that ACh is an endothelium-dependent vasorelaxant 
and some endothelial cells may have been damaged during the dissection and 
mounting of the rings. This seems unlikely since only a small fraction of the 
endothelium needs to be intact for complete relaxation of isolated vasculature to 
occur (Peach et al., 1985). In this study SNP was also more potent than ACh (Fig. 
3.7). It is now well established that vascular smooth muscle relaxation induced both 
by endothelium-dependent vasorelaxants and the endothelium-independent nitro- 
vasodilators, is mediated by cGMP (Rapoport and Murad 1983b).
In this study the vasorelaxant activities of the endothelium-dependent and 
independent vasodilators were shown to be associated with increased levels of cGMP 
(Fig. 3.53, 3.54), measured by radioimmunoassay. The cGMP levels were measured 
in tissues mounted on hooks but in which no tension was applied. Assaying 
cGMP in aortic rings in this way had some advantages and some 
disadvantages. I): by not mounting the rings in an organ bath and applying tension
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to them, this method would be likely to cause less damage to the endothelial cells, 
and obviously this would be reflected in cGMP production in response to 
endothelium - dependent agents. II): since mounting tissues in an organ bath takes 
some time, especially when there are many rings, this method was less time 
consuming, especially since the incubation time was also saved. Ill): since cGMP 
phosphodiesterase (PDE) hydrolyses the cGMP very quickly, the time required to 
remove the tissue from the hooks in an organ bath and terminate PDE activity is 
important. Incubating the aortic rings on hooks in test tubes rather than in organ 
bath simplified the experiment and allowed the tissues to be transferred quickly to 
liquid nitrogen to inactivate PDE and minimise hydrolysis of cGMP. IV): 
measuring cGMP in aortic rings in which the mechanical responses had also been 
recorded would have been desirable, since the conditions under which both 
responses were measured would have been similar.
The major disadvantage of the method used in this study to incubate the rings 
prior to measuring cGMP was that the levels of this nucleotide and the mechanical 
responses to drugs were not measured in the same tissues under identical 
conditions. However, this potential disadvantage was counterbalanced by the speed 
with which PDE could be inactivated by transferring the rings to liquid nitrogen and 
by the reduced risk of damage to the endothelium since the rings were not mounted 
on hooks and no tension was applied. However in spite of the disadvantages, the 
method used in this study was a standard procedure and the limitations applied to 
all experiments, so that a comparison between different relaxants is therefore 
valid.
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It has been shown, by a previous study in our labaratory (Morrison, 1988) that 
extraction of cGMP from aortic rings was more efficient following tissue 
homogenisation, which was thought to increase the surface area across which the 
acid could permeate and therefore increase the yield of cGMP. However, this 
result contrasts with the finding of Bowman and Drummond, (1984), who reported 
that in the bovine retractor penis muscle, tissue homogenisation during acid 
extraction did not significantly increase the yield of cGMP. This discrepancy may 
be due to differences in the tissues. Since the aorta is a tough tissue, it may need to 
be homogenised to enable the acid to penetrate the tissue and increase the efficiency 
of extraction of cGMP. It is possible that the tissue cGMP content is located in 
distinct intracellular compartments (Waldman & Murad, 1987). Furthermore, tissue 
homogenisation may facilitate extraction of concentrations of cGMP that originate 
from different pools. Even if homogenisation had little or no effect on the total 
amount of cGMP extracted, by facilitating access of the acid throughout the tissue, 
it would increase the likelihood that samples of cGMP would be obtained from all 
the compartments within the tissue. Then, if changes in cGMP levels occurred in 
only one or a limited number of compartments within the tissue, this change could 
be detected. Throughout this study, tissue levels of cGMP were measured by a 
radioimmuoassay kit, based on the competitive binding between unlabelled cGMP 
and [3H]-labelled cGMP to an antiserum with high affinity and specificity for cGMP. 
By using pH], a beta emitter, as the isotope label, the radioimmunoassay provided 
a convenient, reproducible and safe means of measuring cGMP.
Acetylcholine (ACh, 10'5 M) and sodium nitroprusside (SNP, 10'6 M), increased 
the levels cGMP in aortic rings in the presence of NA ( E C 7 5 ,  3xl0 '8 M) (Fig. 3.53.
8 0
3.54). Although SNP (10‘6 M) and ACh (10'5 M) relaxed the muscle completely, the 
level of cGMP induced by SNP was 9-fold higher than that induced by ACh. (Fig. 
3.53, 3.54). It therefore appears that SNP increased the levels of cGMP above the 
level required for complete muscle relaxation. The differences in the levels of 
cGMP induced by SNP and ACh may be accounted for by differences in the 
mechanisms leading to stimulation of guanylate cyclase activity. The relaxant effects
i°~f
of ACh are receptor-mediated and require the synthesis and releases EDRF (NO) 
(Furchgott & Zawadzki, 1980). This is probably an ordered process that is regulated 
at various sites by other intracellular mechanisms. In contrast, SNP-induced 
relaxation involves the diffusion of the relaxant across the plasma membrane, after 
which nitric oxide is thought to be generated via an S-nitrosothiol intermediate 
(Ignarro & Kadowitz, 1985). This process appears to be a more rapid but crude 
means of stimulating guanylate cyclase activity and may partially explain the 
different potencies of ACh and SNP in increasing levels of cGMP.
The vasorelaxant agents (ACh and SNP) which increased cGMP synthesis not 
only relaxed NA-induced tone but also inhibited NA-induced Pl-hydrolysis in aortic 
rings. Inhibition of NA-induced muscle tone by cGMP, may occur via several 
pathways. It has been proposed that cGMP may inhibit cq- adrenoceptor mediated 
vascular contraction by Ca2+- independent mechanisms, involving phosphorylation 
and inhibition of myosin light chain kinase (MLCK) via cGMP-dependent protein 
kinase (Nishikawa et al., 1984; Chiesi and Carafoli, 1986). Ca2+-dependent 
mechanisms may also be involved and could include; 1): reducing [Ca2+]j by 
Ca2+-extrusion through the sarcolemma (Popescu et al., 1985; Twort & Van 
Breemen, 1988), 2): inhibition of Ca2+-influx into the cells (Taylor & Meisheri,
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1986), 3): inhibition of Ca2+- release from intracellular Ca2+ stores (Rapoport, 
1986); 4): stimulation of SR-Ca2+-pump (Twort & Van Breemen, 1988).
In addition to these mechanisms for cGMP, Rapoport (1986), suggested that 
inhibition of a r adrenoceptor-induced contraction by agents that increase cGMP 
production, may be partly mediated by inhibition of Pl-hydrolysis. In intact vascular 
tissues, ACh and SNP may inhibit NA-induced contraction by an initial activation 
of guanylate cyclase, with a secondary reduction of IP3 synthesis. This mechanism 
is consistent with that proposed by Takai, (1984), and Watson et al (1984), who 
suggested that cGMP inhibits PIP breakdown in platelets through activation of 
protein kinase G.
In this study, in order to confirm the effect of cGMP, the permeant analogue 
of cGMP, 8 -Bromo cGMP, was used and this analogue also inhibited NA-induced 
Pl-hdrolysis in aortic rings (Fig. 3.37, 4.2). The endothelium- dependent 
vasorelaxant ACh, did not inhibit the Pl-response in aortic rings (Fig.3.35), in 
which the endothelium had been removed either mechanically by rubbing or, 
chemically, by Triton X-100.
This result shows that the endothelium has an essential role both in the production 
of cGMP and in ACh-induced inhibition of the Pl-response (Fig.4.1). However, 
these results suggested that cGMP only partially inhibits the Pl-response, suggesting 
that cGMP-mediated vasorelaxation is only partly due to this effect of cGMP on 
Pl-response.
One possible explanation of this mechanism is based upon the fact that, PLC, 
which is the enzyme that hydrolyses PI, is Ca2+-dependent. Since cGMP lowers 
[Ca2+]j by multiple mechanisms it may be that cGMP inhibits PI- hydrolysis by
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Fig. 4.1.
A schematic diagram showing possible sites of action for cGMP invascular smooth muscle. Both 
the endothelium-dependent vasorelaxant, ACh, and the endothelium-independent vasorelaxant, 
SNP, release NO, which activates guanylate cyclase to produce cGMP, which causes relaxation 
and inhibits the PI mechanism. cGMP inhibits the Pl-hydrolysis but the site of action is still 
unknown.
attenuating Ca2+-dependent PLC activity. cGMP may also have a direct inhibitory 
effect on one of the stages in the PI signal transduction mechanism, such as the 
G-proteins, which are the important components of the Pl-pathway. It is not clear 
where the inhibitory action of cGMP occurs. The precise mechanism by which 
cGMP acts needs further investigation.
Since in vascular smooth muscle there is a second inhibitory mechanism that 
involves cyclic nucleotides, this study investigated the role of cAMP, which like 
cGMP has a vasorelaxant effect. The effects of the 13-adrenoceptor agonist, ISO, and 
directly-acting activator of adenylate cyclase, forskolin were examined. These drugs 
caused vasorelaxation and accumulation of cAMP in aortic rings (Fig. 3.8, 3.9, 
3.55, 3.56).
In this study the 13-adrenoceptor agonists, ISO (10'6 M) (Fig. 3.38) and salbutamol 
(10* M) (Fig. 3.39), inhibited NA- induced Pl-hydrolysis. Since these effects were 
antagonised by propranolol (5x1 O'6 M), it appears that these effects were mediated 
via 13-adrenoceptors. Similar inhibitory effects were obtained with other agents such 
as the directly-acting adenylate cyclase activator, forskolin (10* M) (Fig. 3.42), and 
the phosphodiesterase inhibitors, isobutylmethylxanthine (IBMX, 1x10* M) 
(Fig.3.40), and theophylline (5x10* M) (Fig. 3.41).
The effect of cAMP was confirmed using the permeant analogue of cAMP, 8 -Bromo 
cAMP (3x10* M) (Fig. 3.44), which also inhibited the Pl-response.
This is the first time that it has been shown in vascular smooth muscle, that 
cAMP and cAMP-increasing agents, inhibit the NA-induced Pl-response (fig.4.2).
These results are consistent with the previous results obtained in other tissues,
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Fig. 4.2.
A schematic diagram showing possible sites of action for the cyclic nucleotides (cAMP and 
cGMP) in vascular smooth muscle. These nucleotides, whether synthesised within the cell or 
administered as stable, permeant derivatives, may inhibit the PI mechanism by an action on G- 
protein or on PLC.
including platelets (Takai et al., 1982; Watson et al., 1984), slices of rat kidney 
(Neylon & Summers, 1988) and in tracheal smooth muscle (Hall & Hill, 1989). The 
site of action of the cAMP is at present unknown but G-proteins, PLC and 
phospholipid kinases (which converts PI to PIP and then to PIP2), are the most likely 
sites of action, but the exact sites of action of cAMP in vascular smooth remain to 
be established.
Like cGMP, inhibition of NA-induced muscle tone by cAMP may take place via 
multiple pathways, including; 1): Phosphorylation of MLCK via protein kinase A 
(Chiesi & Carafoli, 1986); 2): Activation of Ca2+-ATPase in sarcolemmal membrane 
(Van Breemen & Saida, 1989); 3): Activation of Ca2+-ATPase in SR membrane 
(Conti & Adelstein, 1981); 4): Inhibition of voltage-dependent Ca2+-channels and in 
turn, inhibition of Ca2+-influx (Ousterhout & Sperelakis, 1984).
cAMP may also influence G-protein functioning and PLC. It is generally accepted 
that when the G-proteins are activated, the heterotrimer (c#B7) dissociatesinto subunits 
(a and By). In the adenylase cyclase (AC) system it has been suggested that, 
activation of G{ (AC inhibitor), opposes the action of the Gf protein (AC activator) 
directly and also indirectly by generating excess GV-subunits, which bind to and 
inactivate Gsa  (Katada et al., 1984). By analogy, it is possible that if the PLC 
activator Gp(s)of interacts with Bt^subunits, then generation of sufficient BY-subunits 
as a result of activation of another G-protein (in this case G„ by B-adrenoceptor 
agonists), will inhibit the activated Gp(s)a.
Another possibility is that Bj^has a directly inhibitory effect on PLC. This is 
consistent with a role of BY in the regulation of PLC in Xenopus oocytes (Moriarty 
et al., 1988), in which injection of purified BY (but not a) inhibited a muscarinic
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response known to be mediated by activation of PLC. This explanation may account 
for receptor-mediated inhibition of PI, but a direct effect of cyclic nucleotides on PI- 
metabolism can not be excluded.
Another possibility for cAMP-induced inhibition is that lowering of [Ca2+]j might 
indirectly inhibit Pl-hydrolysis. This hypothesis has been supported by findings, 
which suggest that in whole cells (Delahunty et al., 1988; Vallar et al., 1988), 
or broken cells (Irvine, 1982), lowering [Ca2+]j inhibits PLC activity, by 
attenuating Ca2+ -dependent PLC activity. However, the precise sites and 
mechanisms of action by which cyclic nucleotides cause inhibition of Pl-hydrolysis, 
is unclear and needs further investigation.
In this study the Ca2+-channel blocker, nifedipine (10~6 M), inhibited the 
NA-induced Pl-hydrolysis in aortic rings (Fig. 3.45). This result suggests that 
extracellular Ca2+ may be required for the maintenance of the Pl-response.
The contraction of vascular smooth muscle induced by a t- adrenoceptor activation 
in rat aorta is believed to be caused either by Ca2+ release from the intracellular 
stores, or Ca2+ influx through Ca2+-channels (Cauvin & Malik, 1984). 
Experimentally, a r adrenoceptor-mediated contraction, can be separated into phasic 
and tonic components; the phasic component seems to be dependent on intracellular 
Ca2+, due to Pl-hydrolysis (IP3) (Rapoport, 1987), while the tonic component 
depends on influx of extracellular Ca2+ (Cauvin & Malik, 1984). Recently Nishimura 
and Ito (1989) and Nishimura et al. (1991), have reported that the tonic contraction 
caused by cej-adrenoceptor activation in rat aorta is composed of two components, 
one of which is clearly associated with the cascade of PI- hydrolysis and probably 
involves protein kinase C. The other component is due to Ca2+ influx through
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nifedipine-sensitive Ca2+-channels.
In NA-induced Pl-hydrolysis, the first part which corresponds to the phasic 
contraction is due to production of IP3, which releases [Ca2+]i from intracellular 
stores and the maintained or tonic contraction, requires influx of Ca2+. This influx 
of Ca2+ has been shown to be caused via one or more metabolites of Pl-hydrolysis 
such as IP3, IP4 or both (Irvine and Moor, 1986). On the other hand, this present 
study has shown that KCl-induced Ca2+-influx can induce Pl-hydrolysis. It has been 
suggested that lowering [Ca2+], inhibits PLC activity (Delahunty et al., 1988) and 
therefore the most likely explanation is that aj-adrenoceptor activation causes an 
immediate release of intracellular Ca2+ by IP3, from stores which are maintained by 
Ca2+ influx caused by IP3, IP4 or both. It appears that the influx of Ca2+ itself helps 
to activate the Pl-hydrolysis since nifedipine, which inhibits Ca2+ -influx, partly 
inhibited Pl-hydrolysis. This result is consistent with those of Rapoport, 1987; Vallar 
et al., 1988; & Delahunty et al., 1988).
SECTION 2: Study of alterations in pharmacological and second
messengers mechanisms in hypertensive rat aorta and 
tail artery.
Essential hypertension is associated with elevated systemic arterial blood pressure 
and is caused by increased peripheral resistance. The mechanisms mediating this 
increase in peripheral resistance, are not clearly understood, and have given rise 
to conflicting reports on the mechanisms of hypertension. Many studies have 
examined the responsiveness of isolated blood vessels from hypertensive animals to
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determine whether any changes in the sensitivity of these vessels occurred and 
whether these might explain the hypertension.
In isolated blood vessels from hypertensive animals both supersensitivity and 
subsensitivity to vasoactive agents have been recorded. (Reviewed by Winquist 
et al., 1982; Mulvany, 1983; Triggle & Laher, 1985). In most of these studies 
only mechanical responses were measured and the related intracellular events were 
not recorded. It is possible that the variation in the results obtained in these studies 
may be due to differences in the model of hypertension chosen and in the 
time-course of the development of the phenomenon, as well as differences in the 
blood vessels and techniques used. The mechanisms of action of the agonists 
investigated may also have affected the results obtained.
The current series of experiments examined the mechanisms of hypertension 
in only one model of hypertension, and sought to relate the mechanical responses 
of tissues to the underlying biochemical changes. Using this approach, it was hoped 
to gain a better understanding of how vascular responsiveness in hypertension may 
change. The model of hypertension chosen for study was that observed in 
spontaneously hypertensive rats (SHR), which are genetically predisposed to this 
condition (Trippodo & Frohlich, 1981). These animals were confirmed to be 
hypertensive in comparison with Wistar Kyoto (WKY) control rats by measuring 
the blood pressure (Fig. 3.11).
Surprisingly, NA produced much weaker contractions in aortic rings from SHR 
than in aortic rings from normotensive WKY control rats (Fig. 3.14). This finding 
is consistent with the work of some workers (Shibata et al., 1973; Swamy & 
Triggle 1980 a,b,; Pang & Sutter, 1980; Templeton et al., 1987). However, other
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reports have shown that blood vessels from hypertensive rats are supersensitive to 
NA, (Bevan et al., 1975); Webb et al., 1981). In contrast, other investigators 
(Clineschmidt et al., 1970; Hallback et al., 1971) have reported that the 
sensitivities of blood vessels from normotensive and hypertensive rats are similar.
In this study the reduced responsiveness of aortic rings from SHR to NA may 
be related to the higher resting tension developed by these tissues compared with that 
recorded ina ortic rings from WKY control rats. It is possible, that SHR aortic rings 
were incapable of developing further substantial tension in response to NA since 
these tissues were already partially contracted.
KCl-induced contractions were smaller in aortic rings from SHR than in those 
from WKY controls (Fig. 3.15). These smaller contractions to KC1 in aortic 
rings from SHR may also be explained by the high resting tension seen in these 
rings. If the contractile proteins in these rings were partially phosphorylated, then 
KC1, acting via potential-operated Ca2+-channels, would only activate the contractile 
apparatus to a limited extent. It is possible that high resting tension in tissues from 
SHR might be due to abnormally high levels of intracellular Ca2+ (Bohr & Webb, 
1988; Dominizak and Bohr, 1989, 1990) in the resting condition due to impairment 
of the mechanisms responsible for reducing [Ca2+]i in hypertension. Furthermore, 
it might be speculated that high levels of [Ca2+]i in hypertension would already have 
bound to the calmodulin and therefore increasing of [Ca2+]i either by activation of 
receptors or depolarisation would be ineffective since there would not be enough 
calmodulin to bind the newly-entered Ca2+. On the other hand, there may have 
been some previously-bound Ca2+- calmodulin, which caused phosphorylation of 
the enzyme and contractile proteins, and prevented normal contraction. Another
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possibility is that because of the high availability of [Ca2+]i in hypertension, the 
affinity of calmodulin for Ca2+ might be reduced. In addition, either 
Ca2+-calmodulin binding, or the consequent phosphorylation event or perhaps even 
the IP3 receptors on the sarcoplasmic reticulum (SR) may undergo desensitization 
so that the aorta is less responsive to contractile agonists in hypertension. This 
observation requires further investigation.
The fact that NA produced smaller contractions in aortic rings from SHR was 
inconsistent with the ability of NA to cause Pl-hydrolysis, in aortic rings 
from age-matched (10-12 weeks) animals (Fig. 3.46), but they were consistent 
with the ability of NA to cause smaller Pl-hydrolysis in older (18-20 weeks) rats 
(Fig. 3.47). In rings from 10-12 weeks rats, low concentrations of NA (10*- 
10~6 M), produced a Pl-response that was larger in rings from SHR than in rings 
from WKY. In this study, it has been shown that in aorta from Wistar rats, 
vasorelaxant agents agents such as ACh, SNP, and isoprenaline, at the 
concentrations in which they can maximally inhibit the NA-induced tone, inhibit 
the Pl-response by less than 50%. These results suggest that even in a situation in 
which 50% of the agonist-induced increase in Pl-hydrolysis remains, the tone is 
completely inhibited. It can therefore be concluded that, although the Pl-hydrolysis 
pathway is important and has a crucial role in triggering Ca2+-release and in the 
initiation of contraction, it may not be a precise or reliable indicator of a 
maintained mechanical response. These results also show that even when the 
coupling mechanism that causes contraction is active, agents which increase the 
synthesis of cGMP or cAMP can have potent vasorelaxant effects so that 
they overcome the contractile mechanisms and as a result, the net effect is
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vasorelaxation. This explanation might be applicable for the results obtained 
with tissues from hypertensive animals.
In aortic rings from SHR, in which the NA-induced Pl-response is high but the 
NA-induced contractions are smaller it is possible that the inhibitory mechanisms 
are more active in aortic rings from SHR than in those from WKY. Such a change 
may be due to an adaptive process in hypertensive tissue. Since, it is known 
that cGMP is produced in response to Pl-hydrolysis (Berridge, 1984), increased 
Pl-hydrolysis might be responsible for producing higher levels of cGMP. Thus a 
more powerful inhibitory mechanism may develop in tissues from SHR, resulting 
in weaker contractions to vasoconstrictors such as NA which causes PI hydrolysis. 
These results are consistent with the finding of others (Heagerty & Ollerenshaw, 
1987), who have shown that agonist-induced Pl-hydrolysis is enhanced at a time 
when the hypertension has not been established. However, with age and after the 
hypertension has been established, the Pl-response is no longer enhanced and may 
even be less than in controls. It is possible that the increased Pl-response may have 
a role in inducing and promoting the development of the hypertension, but once it 
is established, the role of PI would become less obvious because of the enhanced 
cGMP-mediated vasorelaxation.
Sodium nitroprusside-(SNP) induced concentration- dependent relaxations of both 
SHR and WKY aortic rings that had been precontracted with NA (Fig .pf 3.17). At 
low concentrations (3X10-10- 3xl0'9 M) (Fig. 3.17), SNP induced weaker relaxations 
of aortic rings from SHR than of WKY. This result is consistent with that of 
Otsuka et al., (1988), and it is possible that the relaxant effect of SNP at low 
concentrations was attenuated by highly active cGMP phosphodiesterases in aortic
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rings from SHR. This possibility needs to be further investigated.
At higher concentration (10'6 M), SNP induced more powerful relaxations of 
aortic rings from SHR than of rings from WKY (Fig. 3.17). This effect was 
associated with a significantly greater increase in the level of cGMP in aortic 
rings from SHR than in those from WKY tissues (Fig. 3.58). Moreover, this 
effect was also reflected in a greater inhibitory effect of SNP (10'6 M) on 
Pl-hydrolysis in SHR (Fig. 3.49). It is likely that this greater increase in cGMP 
level may account for the enhanced relaxation and bigger inhibition of NA-induced 
PI- hydrolysis in SHR aortic rings.
Acetylcholine (ACh, 10‘6 M) (Fig. 3.57), also caused greater increases in 
cGMP levels and larger inhibitions of NA-induced Pl-hydrolysis (Fig. 3.48) in 
aortic rings from SHR, and this may also be explained by the same mechanism. 
This increased capacity to elevate cGMP levels and relax aortic rings from SHR 
might be due to an adaptation or a compensatory mechanism that is activated in 
response to the high blood pressure. This finding is consistent with the results 
reported by Coquil et al., (1987), who showed that in aorta from SHR, the activity 
of cGMP-dependent protein kinase (PKG) was elevated. Webb et al. (1987), 
also have shown enhancement of vasodilator responses to ACh in hypertensive 
mice aorta, and the same compensatory response in SHR aorta has also been 
reported by Konishi & Su, (1983). However, the results obtained in this study are 
inconsistent with those of other workers (Lee et al., 1987; Shirasaki et al., 1988; 
Otsuka et al., 1988). Elevation of cGMP might be due to higher Pl-hydrolysis in 
SHR rings and in turn, increased production of cGMP, and also decreased activity 
of cGMP-PDE. The 13-adrenoceptor agonist, isoprenaline (ISO, 3xlO‘10-3xlO‘7 M)
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caused concentration-dependent relaxations of NA-induced precontractions in aortic 
rings from both SHR and WKY rats but the inhibitory effect of ISO (3x1 O'10 
-3x1 O'8 M) was less marked in rings from SHR that in those from WKY 
controls (Fig.3.18).
This effect of ISO, (10"8 M) was associated with a reduced ability to increase the 
levels of cAMP in aortic rings from SHR in comparison with rings from WKY 
controls. (Fig. 3.59). This difference was also reflected in smaller inhibitions of 
NA-induced Pl-hydrolysis by ISO (10'6 M) (Fig. 3.50). It is likely that this smaller 
increase in cAMP level accounted for the weaker relaxations and smaller inhibitions 
of NA-induced Pl-hydrolysis in SHR rings. Forskolin (FOR, 10'6 M) (Fig. 3.56) 
also, induced smaller increases in cAMP and smaller inhibitions of 
NA-induced Pl-hydrolysis in rings from SHR (Fig. 3.51), probably for the same 
reason. These results are consistent with those of majority of the investigators 
(Triner et al., 1975; Cohen and Berkowitz 1976; Godfraind and Dieu 1978; 
Asano etal., 1982; Silver et al., 1985; Asano et al., 1988).
Since forskolin was less effective in aortic rings from SHR, it appears that in 
SHR vasculature, the alteration in the cAMP-mediated mechanism occurs at the 
level of the signal transduction mechanism rather than at the B-adrenoceptor. 
Depressed basal and agonist-stimulated adenylate cyclase activity has been 
reported by Ramathan and Shibata (1974), who demonstrated lower levels of cAMP 
in blood vessels of young SHR, in which the level of adenylate cyclase activity 
was significantly lower than in WKY vessels. Others (Triner et al., 1975; Klenerova 
et al., 1975; Fukuda et al., 1990), have also shown this reduced ability to 
stimulate adenylate cyclase. In addition, reduced G-protein function has been shown
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by Asano (1988) in vascular smooth muscle from SHR, in which the cAMP level is 
less than in control, suggesting that reduced G-protein activity is involved in this 
abnormality of the 8 -adrenoceptor adenylate cyclase system.
It is possible that the reduced cAMP level occurs as a result of increased 
cAMP-PDE activity, which hydrolyses more cAMP. This also needs to be further 
studied. It may also be possible that cGMP-activated PDE hydrolyses the cAMP 
(Beavo & Reifsnyder 1990). The results obtained with nifedipine were also 
complex. Nifedipine (NIF, 10'9-3xl0'6 M) caused smaller inhibitions of KC1- 
induced tone in aortic rings from SHR than in rings from WKY. In addition low 
concentrations of NIF (lO ^x lO '8 M) caused smaller inhibitions of NA-induced 
tone in rings from SHR than in those WKY, but higher concentration of NIF (Id  
6-3xl0'6 M) produced larger inhibition of rings from SHR than WKY. A possible 
explanation for these results is that aortic rings from SHR are more dependent on 
intracellular Ca2+ and so are less dependent on extracellular Ca2+ than those from 
WKY controls.
The difference between these two results may reflect the different 
mechanisms by which the precontracting agents mobilise Ca2+. Since, KC1 
depolarizes the cell membrane and causes an influx of Ca2+ through VOCs, NIF is 
an appropriate drug for studying the effect of KC1. However, NA uses both 
intracellular and extracellular Ca2+. In the case of NA-induced tone, with a 
low concentration of NIF, the results were the same as with KCl-induced tone. 
However, with high concentrations of nifedipine, the results were different. A 
possible explanation of this observation may be that while intracellular [Ca2+]j is 
available, vascular smooth from SHR is more dependent on it, than that from WKY
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rats. However, once these stores have been depleted and are no longer available, 
no refilling or replacement of Ca2+ occurs so that, the hypertensive muscle then 
would become more dependent on extracellular Ca2+ than normotensive muscle. 
These results indicate that changes do occur in the responsiveness of isolated 
vasculature from hypertensive rats. Surprisingly, these changes in responsiveness are 
in the opposite direction to what might have been expected. Reduced responsiveness 
to contractile agonists and increased responsiveness to vasodilators is 
unexpected and certainly could not explain the marked hypertension present in the 
SHR. It is more likely that such changes reflect an adaptation to the hypertension 
rather than an explanation of it. The aorta is a conducting vessel which does not 
contribute to the peripheral resistance but it could be influenced by prolonged 
elevation of the peripheral vascular tone.
The results obtained with the tail artery were notably, different from 
those obtained in aortic rings. In this case, the changes in responsiveness may well 
be associated directly with the hypertension. These studies not only showed that the 
tail artery rings from SHR were heavier than those from WKY controls (Fig. 
3.13) but were also more responsive to NA. When the responses to NA in isolated 
tail artery rings were measured as changes in isometric tension, the maximum 
response in rings from SHR was greater than that obtained in rings from WKY 
controls (Fig. 3.21). However, when these results were expressed as a percentage 
of the maximum response (Fig. 3.22) there was no shift in the curve, indicating 
that there was no changes in the sensitivity in the conventional sense but there 
certainly was an enhanced maximum respone to NA in the tail artery rings from 
SHR. This enhanced responsiveness was also seen in the ability of NA to cause
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Pl-hydrolysis in tail artery rings from SHR (Fig. 3.52). Thus, the enhanced 
mechanical response was consistent with the enhanced biochemical response. It was 
notable that in both cases the increased responsiveness was only seen at the highest 
concentration of NA.
When the responsiveness of the isolated tail artery was examined in 
isolated perfused segments rather than in isolated rings (Fig. 3.23), similar results 
were obtained but the magnitude of the enhancement of the maximum response to 
NA was much greater in perfused segments than in isolated rings. As with the 
isometric tension recording the concentration-response curves were superimposable 
at the lower concentration ranges. Only at higher concentrations was any 
difference seen. The increase in maximum response in tail artery segments from 
SHR compared to WKY controls was approximately 300%, whereas it was 
approximately 40% when the response are measured as changes in isometric 
tension. This enhancement of the response probably reflects the vascular wall 
thickening and the Laplace effect i.e. a small increase in tension is manifested as 
a large increase in perfusion pressure (Guyton, 1986). When these results were 
expressed as a percentage of the maximum response (Fig. 3.24) there was a 
rightward shift of the curve for perfused segments from SHR compared to the 
curve for perfused segments from WKY rats. This could be interpreted as 
subsensitivity but is more likely to have arisen because the maximum response was 
exaggerated as a result of the vascular wall thickening. No significant change in 
sensitivity or responsiveness to KC1 was seen in tail artery segments (Fig. 
3.25, 26, 27, 28). However, with both tension recording and perfusion studies 
there was a tendency toward a decreased responsiveness of tail artery segments
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from SHR to KC1. No shift of the curve was seen when the results were expressed 
as a percentage of the maximum response. It is possible that in the tail artery rings 
any decreased responsiveness to KC1 in the segments of the SHR might have been 
masked by KCl-induced NA release from nerve terminals.
These results indicate that the results obtained in a particular blood vessel depend 
upon the method used to record the response. A small increase in responsiveness, 
measured as tension in isolated rings, was amplified when the blood vessel was 
perfused and the response was resistance to the perfusion. It seems likely that the 
tail artery, which is a resistance vessel and is unlike the aorta, there is an increased 
capacity to respond to NA. This may be related to the hypertension that occurs in 
SHR but further work is required to confirm this association.
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